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The Improving Access to Psychological Therapies (IAPT) initiative was launched in 
2008 in the United Kingdom (UK) to offer evidence-based psychotherapies to patients with 
anxiety and depression in a stepped care service delivery model. The programme reports 
evaluation data in the form of monthly and annual reports of recovery rates by service and 
care commissioning group. In recent years the plurality of intervention in this programme has 
also been expanded  
A systematic review and meta-analysis was conducted to review the published 
practice-based studies arising from the first 10-years of the English IAPT programme, 
focussing on the effectiveness of IAPT interventions delivered in routine practice. A total of 
60 studies were included overall, with n=29 of those making up the meta-analysis. Results 
found large pre-post treatment effect sizes for depression and anxiety, and a medium pre-post 
treatment effect size for functional impairments. Implications for future work include 
exploring how IAPT can become more effective for people with comorbid long-term 
conditions and medically unexplained symptoms and improving the designs of practice-based 
studies. 
The research report investigated the effectiveness of cognitive analytic therapy (CAT) 
within the IAPT programme at step 3 (high intensity). Outcome comparisons with the 
‘treatment as usual’ intervention offered at step 3 (i.e. cognitive behavioural therapy; CBT) 
were completed. Longitudinal multilevel modelling (MLM) was used to investigate 
symptomatic changes over time and between groups. Results suggest equivalence between 
CAT and CBT in an IAPT setting. CAT and CBT trajectories of symptom change do not 
appear to differ over time during the therapies. Implications for CAT being offered as a first-
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Abstract 
Objectives: To review the first 10-years’ worth of practice-based studies arising from the 
English Improving Access to Psychological Therapies (IAPT) programme. 
Methods: A systematic review and meta-analysis was conducted. Three databases (SCOPUS, 
PsycINFO, MedLine) were searched for relevant articles. Inclusion criteria were utilised and 
included studies focusing on working age adults, quantitative methodology, and the inclusion of 
validated outcome measures for at least two time points. A narrative overview of the studies is 
included, describing the characteristics of the studies (e.g., outcomes analysed, step of treatment, 
demographic variables). A meta-analysis is included from those studies reporting appropriate 
metric pre-post treatment outcomes: (means and standard deviations, or Cohen’s d effect sizes). 
Subgroup analyses examine the potential influence of particular methodologies, treatments, 
populations or target conditions. Sensitivity checks investigated influential heterogeneity and 
bias, and articles are quality assessed. 
Results: N=60 studies were included in the systematic review, with n=47 reporting metrics that 
could be used in the meta-analysis. The studies include a range of treatments delivered at both 
step 2 (low intensity) and step 3 (high intensity). The primary meta-analysis indicated a large 
pre-post effect size for reductions in depression (d = 0.87) and anxiety (d = 0.88), and a medium 
effect regarding reductions to impairment (d = 0.55). Differing features of the studies influenced 
the size of the effect found, such as whether intention-to-treat or completer analyses were used. 
Conclusions: IAPT interventions produce large effect sizes in routine practice, with the 
programme increasing access for large populations. Limitations of the review and future clinical 
implications are discussed. 
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Practitioner points:  
• Group interventions appear similarly effective as individual sessions and could be 
implemented more often within services which would increase number of patients seen as 
well as be an efficient use of staff resources without reducing clinical outcomes 
• Disorder specific outcome measures are very limited in use within the IAPT literature 
and thus this questions whether therapists are adequately capturing change. Practitioners 
should adopt measures well attuned to the presenting problem 
• The use of adherence, competency and treatment integrity measures are lacking within 
the literature, which raises uncertainty about whether this is reflective of what is 
happening within clinical practice. The use of such measures within IAPT should be 
integrated into everyday practice and reported in the research literature 
• Future service needs include further expansion of the programme (e.g., continuing the 
understanding and specialised treatment in those with co-morbid long-term 
conditions/medically unexplained symptoms) 
• IAPT has integrated large-scale and transparent outcome monitoring practices throughout 
the programme which is consequently allowing for the continued evaluation of practice-
based evidence 
 
Keywords: Improving Access to Psychological Therapies, IAPT, meta-analysis, outcome 
measures, depression, anxiety. 
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1. Introduction 
In the United Kingdom, the National Institute for Health and Care Excellence (NICE) 
guidelines support the implementation of evidence-based psychological interventions for 
common mental health problems (e.g. depression, anxiety disorders, obsessive-compulsive 
disorder and post-traumatic stress disorder; NICE CG90; NICE CG113). These guidelines were 
implemented at a population level in 2008 in England through a national programme called 
Improving Access to Psychological Therapies (IAPT). IAPT is based on the funding assumption 
that patients receiving an evidenced-based psychological therapy would likely recover, return to 
work and so reduce welfare benefit costs (Clark et al., 2018). Full implementation (via initial 
pathfinder sites) was based on the development and evaluation of two ‘demonstration sites’ in 
Doncaster and Newham (Clark et al., 2009). IAPT addresses the increased demand for 
psychological therapies in services organised via the principles of ‘stepped-care’. It has 
continued to grow and develop since its inception and is now inclusive of all age groups (e.g., 
children and older adults) and patient groups (e.g., military veterans and people with long-term 
health conditions). Patient choice has expanded to include offering therapies other than cognitive 
behavioural therapy (CBT; e.g. interpersonal psychotherapy, dynamic interpersonal 
psychotherapy, counselling for depression and couple work focal to depression).   
IAPT implementation was based on recruiting and training a new psychological 
workforce. A significant proportion of this workforce were low intensity practitioners (called 
psychological wellbeing practitioners; PWPs) working with mild-to-moderate anxiety and 
depression at the lower step of the model. Traditional (mainly CBT) therapists working with 
moderate-to-severe anxiety and depression provide therapy at the higher step (The Depression 
Report, 2006; Clark et al., 2009). National training curricula for both low and high intensity 
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IAPT therapists mean that services deliver the same protocol-driven psychological interventions 
(Health Education England). A competencies framework was developed to support the delivery 
of the CBT treatment protocols (IAPT Programme ‘competency framework’, 2007). 
Implementation of clinical and case-management supervision guidelines for IAPT support the 
stepped-care approach, ensure fidelity to treatment protocols and reduce therapeutic drift (IAPT 
Supervision Guidance, 2011).   
The IAPT stepped care approach offers an effective, brief and less intensive intervention 
as a first step, before reviewing and either ‘stepping up’ or ‘stepping down’ should it be 
necessary. Low intensity interventions are based on cognitive-behavioural theory, are brief (6-8, 
35 minute sessions) and can be delivered over the telephone, in large groups or in a one-to-one 
format. Low intensity treatment uses a guided and psychoeducational self-help approach with 
PWPs acting as coaches rather than traditional therapists (Turpin, 2010). Step 3 interventions are 
based in a formulation-driven approach, are lengthier (typically the protocols define 16 sessions) 
and typically delivered one-to-one (Roth & Fonagy, 2005). Brief and less intensive interventions 
are cost effective with a low intensity treatment costing £1,043 per patient, in comparison to high 
intensity costs of £2,895 per patient (Radhakrishnan et al., 2013).   
The collection of sessional outcome measures is a key feature of the IAPT programme.  
This meant creating a standardised set of generic outcome measures matched to the presenting 
problems commonly encountered in this setting – known as the ‘minimum data set’ (MDS). The 
MDS includes a measure of depression symptomatology (Patient Health Questionnaire (PHQ-9)) 
(Kroenke, Spitzer & Williams, 2001), a measure of anxiety symptomatology (Generalised 
anxiety disorder (GAD-7)) (Spitzer, Kroenke, Williams, & Lowe, 2006), and a measure of 
functional disability (Work and Adjustment Scale (WSAS)) (Mundt, Marks, Shear, & Greist, 
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2002). ‘Disorder-specific’ measures are also used pre-post when relevant to the individual client 
and their presenting difficulty (National IAPT guidance, 2010), such as the Obsessive 
Compulsive Inventory (OCI; Foa, Kozak, Salkovskis, Coles, & Amir, 1998). The MDS is used to 
calculate the numbers of patients who ‘reliably recover’ following an IAPT intervention (i.e. the 
case moves below the caseness threshold on all measures at the end of treatment).   
PWPs, therapists and services expected to attain a 50% recovery rate (this counts the 
number of patients who were above the clinical threshold on depression and/or anxiety at pre-
treatment, with recovery occurring if a patient subsequently scores below the clinical threshold 
on depression and anxiety at the end of treatment). This 50% figure is drawn from the results of 
the clinical trials that make up the evidence base that forms the NICE guidelines. IAPT service 
outcomes are presented monthly as well as bi-annual full programme reports in aggregated forms 
and IAPT has chosen to use the ‘recovery’ indicator to assess effectiveness. Approximately 7.5 
million referrals have been received by IAPT services since 2012/13 (when the national data 
outputs are available from) to the latest data output (2017/18), with an average of 1.25 million 
referrals. From this same data, around 4.9 million patients started treatment with just over 2.6 
million patients being recorded as having completed treatment. Treatment duration across IAPT 
services is typically seven sessions (data from December 2018: Health and Social Care 
Information Centre, 2019). 
In its first 3 years, IAPT treated one million individuals and recovery rates were slightly 
below the 50% target (NHS England, 2015). For example, in 2015, 44% of treatment finishers in 
the IAPT service made a ‘reliable recovery’ (Briefing Paper, 2015). In the latest national 
statistical report this target has been met as recorded by the Health and Social Care Information 
Centre and is at 51.5% (Health and Social Care Information Centre, March 2019). Clearly, a 
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huge amount of investment has occurred to enable and then maintain the IAPT programme and it 
has transformed the landscape of psychological services for people with anxiety and depression 
in the UK (Firth et al., 2019) and the programme has also served as a model for other national 
implementation programmes (e.g. Australia, Germany and Canada). 
It has been 10 years since the implementation of the IAPT programme, and first 
demonstration site evaluations (Clark et al., 2009). The implementation of evidence-based 
practice, through the use of the NICE guidelines and stepped-care, has shaped IAPT as a 
programme to deliver highly standardised psychological interventions. However, research that 
makes up the greatest influence on national guidelines such as those of NICE is based on highly 
rigorous clinical trial studies that utilise randomised controlled trials (RCT) methodology. Whilst 
this type of research is undeniably scientifically useful and in studies which are high in internal 
validity, it does this at the expense of external validity. Instead, practice-based evidence studies 
(i.e., lower internal reliability, but high external reliability) of real-world clinical services, also 
serve a function, particularly in terms of the generalisability of the clinical trial evidence. IAPT 
can be defined as a national practice-research network in that it is implementing evidenced-based 
practice at a national level, but in a practice-based context. The establishment and growth of 
IAPT over the last 10 years has seen the collection of treatment outcomes from large samples. 
Thus, IAPT offers a unique insight into the pros and cons of attempts to scale up any 
psychological service delivery model to a national level. Over the last decade, a range of studies 
have been published, but to date no systematic review or quality appraisal and meta-analysis of 
the IAPT evidence base has been completed.  
1.1 Aims 
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The aim of this systematic review and meta-analysis was to review the published 
practice-based studies arising from the English IAPT programme conducted since its inception. 
The study sought to exclude clinical trials and to focus on the effectiveness of IAPT 
interventions delivered in routine practice. This review aimed to supplement nationally available 
metrics of improvement with conventional effect sizes to enable comparison with the wider 
psychological therapies for depression and anxiety literature. The review is timely, after ten 
years of implementation work. This is the first known example of a meta-analysis of studies 
underpinning a national-level psychological services implementation programme. As this is the 
first review of its kind, a secondary aim was to also narratively detail the characteristics of 
outcome studies of the IAPT initiative over the last 10-years. 
 
2. Methods 
2.1 Study protocol registration 
The study protocol for this meta-analysis was prospectively registered in the PROSPERO 
website: CRD42018114796. 
2.2 Inclusion and exclusion criteria 
Articles were included in the review if they met the following inclusion criteria: i) the 
main focus population was working age adults (i.e., 18 years and over); ii) the study design 
included the analysis of validated outcome measures and included at least two points of outcome 
data collection; iii) the studies were published in a peer-reviewed journal; iv) the article was 
written (or translated) into English; v) the IAPT service was UK-based; vi) quantitative 
methodology was employed. Table 1 sets out the operationalised inclusion criteria. Exclusion 
criteria were: i) the focus of the study was on children/adolescent populations; ii) outcome 
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measures were collected at one time-point only; iii) the study design was experimental in nature 
(e.g., RCT); iv) the article was not a peer-reviewed publication; v) the article was not in English 
(or not translated into English); vi) the IAPT service was not UK-based; vii) purely qualitative 
methodology, opinion pieces or editorials. 
 
Table 1: Operationalised inclusion criteria 
Detail Operationalised inclusion criteria 
Participants Adults who have received treatment from an IAPT service (18 years and over, no 
upper age limit). Those studies that focus on adult populations, but which include 
some individuals younger than 18 years old will be included. 
Intervention All psychological treatments received by individuals in the context of the IAPT 
service (UK), such as cognitive behavioural therapy (CBT), interpersonal therapy 
(IPT) and counselling. All formats will also be captured, e.g., face-to face 1:1, group-
based and computer-based. 
Comparator None. 
Outcomes Primary outcomes: those that measure the range of mental health difficulties that 
individuals experience treated in IAPT services, such as measures of depression 
(PHQ-9) and anxiety (GAD-7), collected at a pre- and post- treatment time point. 
Secondary outcomes: any other measures that are captured during routine clinical 
practice by IAPT services. 
Setting UK-based IAPT services. 
Study design Pre-post designed practice-based evidence studies. 
 
2.3 Literature search strategy 
Three databases were searched for appropriate articles – SCOPUS, PsycInfo, Medline – 
up until the date of 13-08-2018. The search terms utilised were: “Improving Access to 
Psychological Therapies” AND/OR IAPT OR “stepped care” NOT “International association for 
plant taxonomy”. As the IAPT initiative first commenced in 2008, the search years were 
inclusive of 2007-current date.  
The process for capturing all relevant peer-reviewed articles relating to the review 
question followed several components: i) a systematic search of the three databases using the 
pre-determined search strings which were operationalised to capture all relevant articles; ii) hand 
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searching which involved searching the reference lists of those articles that met inclusion 
criteria; iii) of those articles meeting inclusion criteria from steps 1) and 2) a backward/reverse 
citation search was completed to capture any other articles relevant to the review. 
2.4 Eligibility of relevant articles 
Sixty studies met the inclusion criteria, with n=29 reporting sufficient statistical 
information to enable a meta-analysis of their results. For those studies that did not report 
statistics that were extractable for the meta-analysis (n=31), then the corresponding author of the 
article was contacted by email and requested to supply the relevant study statistics.  This resulted 
in accessing data from n=18 additional studies and enabled these studies to be included in the 
meta- analysis. A narrative synthesis was also carried out including all eligible studies. The 
PRISMA diagram (Moher, Liberati, Tetzlaff, & Altman, 2009) details the process of study 
selection (Figure 1). This process followed two stages which was completed by one author in the 
first instance (SW), and any queries about eligibility were discussed and ratified at subsequent 
research meetings including three members of the research team (JD, SK, SW). The eligibility 
process initially reviewed and removed inappropriate articles (i.e., duplicates), followed by the 
reviewing of the title and abstract, and finally by accessing and reviewing the full-text. A 
bespoke data extraction tool was used and contained the following items: author/year, service, 
mental health condition, analysed N, dropout N, analysis (intention-to-treat, or completers 
analysis), intervention, main findings and outcome measures. Any issues likely to create bias 
were also noted on the data extraction tool. 
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Records identified through 
database searches: 2782 
Records after removal due to 
duplication: 1970 
Duplications removed = 812 
 
Stage 1: Titles/Abstracts 282 
Records excluded based on 
title/abstract: 1688 
Reasons for exclusion given in Appendix 2 
 
 
Stage 2: Full texts 60 
Records excluded based on full 
text: 222 
Reasons for exclusion given in Appendix 2 
 
Included studies within narrative synthesis: 60*a 
 

































Included studies within meta-analysis: 47 
 
Figure 1: PRISMA diagram of included papers throughout 
eligibility stages 
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2.4 Quality assessment and risk of bias 
The Critical Appraisal Skills Programme (CASP) tool was used to assess the quality of 
included studies (Downloaded from: https://casp-uk.net/casp-tools-checklists/). A quality 
assessment is a crucial element of the research process due to the large variations between the 
rigor of individual studies. Certain elements of the study, which may be due to methodological 
flaws, may influence important variables and thus lead to confounding effects. Whether or not 
these biases are captured and taken into account during the analysis process will be important in 
understanding whether the treatment effect is biased by these confounding factors and thus to 
what extent the reported results are truly due to the manipulation of the independent variable 
(IV) and thus how robust a study’s findings are. In addition, not only does the quality assessment 
capture the potential biases or limitations of a study, it is also used to capture the strengths of a 
particular study to further understand the robustness of the results. 
One researcher completed the quality assessment for all studies (SW) followed by blind 
rating by two other raters (rater 1 = CBT therapist; rater 2 = clinical psychologist).  The process 
for secondary ratings involved the raters assessing a random selection of papers. Rater 1 rated 
twelve papers (which represented 20% of the studies), and rater 2 rated six papers that 
overlapped with rater 1 (which represented 10% of the studies). The process for this consisted of 
splitting the 60 included papers into study quality groups and taking a random selection to cover 
all quality levels. The raters were blind to initial quality scores. Once completed, the ratings were 
compared, and any discrepancies were discussed. An overall agreement consensus for the rating 
of each paper was completed where possible. Where this was not possible, other members of the 
research team not involved in quality rating were consulted (JD, SK). Interrater reliability was 
calculated using Cohen’s kappa value (Cohen, 1960) and was calculated from initial ratings. 
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Based on Cohen’s kappa interpretations, the agreement was deemed to be ‘moderate’ between 
the original rater and rater 1 (k = 0.526 95% CI 0.430-0.662), and between the original rater and 
rater 2 (k = 0.546 95% CI 0.369-0.683). 
The overall score for each paper can be found in Table 3 (the full quality assessment for 
each paper can be found in Appendix 3). 
2.5 Data synthesis: narrative review and meta-analysis 
A narrative synthesis aimed to summarise key study characteristics. A random effects 
meta-analysis aimed to synthesise the available outcome data (i.e. pre-post treatment, within-
group effect sizes derived from available statistics). Analyses were conducted using R packages 
metafor via MAVIS: Meta-analysis via Shiny and forestplot (R version 3.6.3) (Gordon & Lumley, 
2019; Hamilton, Aydin & Mizumoto, 2016; Viechtbauer, 2010). Inclusion criteria for meta-
analysis were: (1) reporting pre and post means and SDs convertible into an effect size (ES; 
Cohen’s d; Cohen, 1988), (2) reporting Cohen’s d effect size or, (3) reporting other ESs, but with 
sufficient additional information (i.e., means/SDs) to enable Cohen’s d to be calculated or (3) 
reporting the mean pre-post change and SD. The calculation for Cohen’s d was:  
d = (M1 - M1) ⁄ SD pooled 
where, SD pooled = √((SD12 + SD22) ⁄ 2) 
Cohen’s power primer definitions (Cohen, 1988) were used to interpret ESs: ‘small’ (d = 
0.2), ‘medium’ (d = 0.5) or ‘large’ (d = 0.8), with anything <0.2 classified as ‘negligible’.  Forest 
plots summarize the ES for each study, as well as the pooled (combined) depression, anxiety and 
functioning ESs across studies. Numbers needed-to-treat (NNT) results are provided for each of 
the outcome measures to increase the clinical significance of the meta-analysis results.  
Publication bias was assessed using funnel plots (Egger, Davey, Smith, Schneider & Minder, 
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1997) and by using the fail-safe N (Orwin, 1983) and rank correlation tests (Begg & Mazumdar, 
1994).  Heterogeneity was examined using the I2 statistic and Cochrane’s Q test. Moderator 
analyses examined potential sources of heterogeneity in between-study ES. Subgroup analysis 
investigated five categorical variables; methodological design (intention-to-treat/completer), step 
of care (step two/ step three/ step two & three), primary condition (mental health only/comorbid 
physical health), format (individual/group) and risk of bias (low/medium/high).  Meta-regression 
investigated four continuous variables; gender, age, mean baseline score and treatment duration. 
The alpha threshold for significance was adjusted to p < 0.01 for subgroup and meta-regression 
analyses to account for multiple testing. 
3. Results 
3.1 Characteristics of included studies 
 Table 2 describes individual characteristics of the included studies (n=60). Table 3 
outlines the main findings from each study and the associated quality assessment ratings (CASP). 
Tables 4 and 5 provide a summary of the moderator analyses performed on studies included in 
the meta-analysis.
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Table 2: Overview of papers 
First Author & 
Year 
Service(s) Mental health 
condition(s) 






Adamson et al 
(2015)† 
Lincolnshire IAPT 






627 93 ITT Step 2 or Step 3 PHQ-9 GAD-
7 




MH symptoms or 
functional 
impairment 
1376 Not specified Completers Low intensity PHQ-9 GAD-
7 
Ali et al (2017) Single IAPT service Common MH 
problems 
439 165 Completers*1 Previous course of 











63 clients*2 (with 
63 partners) 





Binnie & Boden 
(2016) 
Single outer London 
Borough IAPT 
service 
Not reported 140 61 Completers*3 CBT PHQ-9 
GAD-7 
Branson et al 
(2015) 
University of 










Branson et al 
(2018) 
University of 




Mild to moderate 
anxiety and/or 
depression 
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scales 
Buckman et al 
(2018) 












Burns et al 
(2016)† 





801 261 Completers Step 2 ‘Stress 





Chan et al 
(2014)† 
Single Suffolk IAPT 
service 






12 (3 from low 
intensity; 9 from 
high intensity) 




Cheston et al 
(2016) 
Single South-West 










Clark et al (2009) Two IAPT 








sample = 60) 
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Not reported Completers Not specified PHQ-9 
GAD-7 





Mild to moderate 
MH difficulties 





Delgadillo et al 
(2014)† 





2891 Not specified ITT Step 2 (low 
intensity) and Step 
3 (high intensity) 
PHQ-9 
GAD-7 
Delgadillo et al 
(2014) 





1850 511 (35.1%) ITT Low intensity PHQ-9 
GAD-7 
Delgadillo et al 
(2016) 
211 identifiable 




110415 Not specified ITT Not specified PHQ-9 
GAD-7 
Delgadillo et al 
(2016)† 










Delgadillo et al 
(2016) 





1347 Not specified ITT Step 2 (low 
intensity) and Step 




Delgadillo et al 
(2017)† 





problems with or 
without LTCs 
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(Low intensity = 
32.2%; High 
intensity = 28.5) 
ITT 
 






Delgadillo et al 
(2017) 














Range of MH 
issues 























366 289 (40.1%) ITT Not reported PHQ-9 
GAD-7 
WSAS 

















Green et al 
(2014)† 
Six IAPT services 
located within the 
North of England 
Not reported 1122 0 ITT Step 2 PHQ-9 
GAD-7 
Griffiths et al 
(2014) 
Four IAPT services 








25034 0 ITT Not specified PHQ-9 
GAD-7 
WSAS 
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Gyani et al 
(2013) 








Hammond et al 
(2012) 
N=7 IAPT services 
in East of England 
region 
Not reported 4106 0 ITT Low intensity – 











LTCs or MUS 
Step 2 = 28 
 
Step 3 = 28 
Not specified Completers Step 2 (“Mind and 
Body” CBT-based 






(step 2 only) 
Jolley et al 
(2015)† 
SLaM – IAPT-SMI 
demonstration site 
Service users with 
psychosis 
experience 


























LTCs or MUS. 
1016 130 ITT Step 2 (low 
intensity) and Step 
3 (high intensity) 
PHQ-9 
GAD-7 
Kellett et al 
(2017)† 
Single IAPT service Depressive 
symptoms 
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and co-morbid IBS 










65 7 ITT Systemic therapy PHQ-9 
GAD-7 
CORE-OM 







Lucock et al 
(2018)† 














Luik et al (2017)† NHS-funded charity 










Matthew Prina et 
al (2014) 
Six IAPT services in 




16236 4931 ITT Step 2 and Step 3 PHQ-9 
GAD-7 
McDevitt-










Meadows et al 
(2017)† 
Single IAPT service Depression and/or 
anxiety 
10 7 Completers Step 2 – CAT-SH PHQ-9 
GAD-7 
WSAS 
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Methley et al 
(2016) 








Mofrad et al 
(2014) 









Morrison et al 
(2014)† 




little or no 
comorbid anxiety) 






Murray (2017) Single East of 
England IAPT 
services 
PTSD 57 (PHQ-9 & 
GAD-7), 21 
(IES-R) 
Not reported Completers Step 3 – TR-CBT PHQ-9 
GAD-7 
IES-R 
Pack et al 
(2014)† 
Single IAPT service Low self-esteem 50 39*6 Completers CBT group PHQ-9 
GAD-7 
RSES 
Pereira et al 
(2016) 
One IAPT service Depression and/or 
anxiety 




Pettit et al (2017) South West of 
England IAPT 
services 





Not reported Completers Not reported PHQ-9 
GAD-7 
Poots et al (2014) Single (Westminster) 
IAPT service 
Depression 1426 3208 Completers Not reported PHQ-9 
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Pybis et al 
(2017)† 
(Up to) N=121 IAPT 
services involved in 
the 2nd NAPT 
Depression and/or 





(CBT n = 23595; 
Counselling n = 
9648) 
9262 ITT Step 3 CBT and 




et al (2013)† 
N=5 PCT IAPT 
services, East of 
England 




Richards et al 
(2011)† 

































16636 (split into 
two samples): 
 
n = 8321; 
n = 8315 
Not specified ITT Step 1 (‘brief 
interventions’) and 





Phobia scale – 
self-rating 
Saxon et al 
(2017) 
Not specified Common MH 
problems 
4034 Not reported Completers Step 3 Counselling 
or CBT 
PHQ-9 





29 Not reported Completers Not reported PHQ-9 
GAD-7 
Vaillancourt et al 
(2015) 




Time 1 = 454 
Time 2 = 534 
Step 2: Time 1 = 
29%; Time 2 = 
22% 
 
Step 3: Time 1 = 
17%; Time 2 = 
19% 
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Wright et al 
(2015)† 




depression or other 
common MH 
difficulties 
24 0 ITT DIT PHQ-9 
GAD-7 





phase of service 
development 
















depression in Deaf 
BSL clients 
Standard IAPT: 




(pre) and 366 
(post) 
Not specified Completers Step 2 or Step 3 PHQ-9 
GAD-7 
† indicates those studies included in the meta-analyses. 
MH = mental health; BCT-D = Behavioural Couple Therapy for Depression; CSI-4 = Couples Satisfaction Index (4-item); CTS-R = Cognitive Therapy Scale-Revised; AUDIT-C = Alcohol Use Disorders 
Identification Test-Consumption; QoL-AD = Quality of Life in Alzheimer’s Disease; CORE-OM = Clinical Outcomes in Routine Evaluation-Outcome Measure; SAPAS = Standardised Assessment of 
Personality – abbreviated scale; SEMCD scale = Self-efficacy for Managing Chronic Disease Scale; CHOICE = Choice of outcome in cognitive therapy for psychoses; WEMWBS = Warwick-Edinburgh 
Mental Wellbeing Scale; PSYRATS = Psychotic Symptom Rating Scales ; EQ5D = EuroQol Group (Quality of Life questionnaire); ISI = Insomnia Severity Index; IES-R = Impact of Events Scale – Revised; 
SCS-SF = Self-Compassion Scale Short-Form; ERQ = Emotion Regulation Questionnaire; RSES = Rosenberg’s Self-Esteem Scale; DHP = Diabetes Health Profile; SDSCA = Summary of Diabetes Self-Care 
Activities’ questionnaire; HbA1c = glycosylated haemoglobin; BDI = Beck Depression Inventory;  
LivDem = Living Well with Dementia; OTT = Over the telephone; FTF = face-to-face; BAG = Behavioural Activation in Groups; DIT = Dynamic Interpersonal Therapy; SMArT = Self-Management After 
Therapy; TR-CBT = Trauma-focussed CBT. 
Thames Valley LETB = Thames Valley Local Education and Training Board; CCG = Clinical Commissioning Groups; PWP = psychological wellbeing practitioners; SLaM = South London and Maudsley NHS 
Foundation Trust; IAPT-SMI = Improving Access to Psychological Therapies for people with Severe Mental Illness; PCTs = Primary Care Trusts; BTSS = Berkshire Traumatic Stress Service; NAPT = 
National Audit of Psychological Therapies; BSL = British Sign Language. 
LTC = long-term conditions; MUS = medically unexplained symptoms; IBS = Irritable Bowel Syndrome; PTSD = Post-traumatic stress disorder; T2DM = Type 2 Diabetes Mellitus. 
*1 Those who completed treatment were recruited and following this stage the data was analysed using ITT (survival analysis) of all participants, even those lost to follow-up. 
*2 Clients data only reported within this review 
*3 Completers analysis used for the outcomes from CBT intervention. However, this study does compare those who dropped out with the rest of the sample on other variables, such as demographics. 
*4 Some missing data and not used, but analysis included dropouts. 
*5 Doncaster outcomes are reported in full in another paper (Richards et al., 2011) and therefore, only Newham data from the Clark et al (2009) paper will be used 
*6 ‘Non-completers’ used – no information about whether this includes only those who dropped out or others also. Therefore, this figure is an approximate. 
*7 Estimate based on information given within the paper, as unsure that enough data is available to determine. 
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3.2 Narrative synthesis 
3.2.1 Demographics 
 There were a number of sources of heterogeneity regarding the characteristics of the 
studies. The included n in each study ranged from a case study (n = 1; Mofrad & Webster, 2014), 
to data from 209 clinical commissioning groups (CCGs) (n = 537,131; Clark et al., 2018) 
(median = 997; average = 16,025). One study included only male patients (Adamson et al., 2015) 
and 17 studies that did not report/specify gender demographic data. Of those studies that reported 
gender, the percentage of females reported ranged from 7.7% (Clarkson et al., 2016; military 
sample) to 100% (case study; Mofrad & Webster, 2014) (median = 64.3%; average = 60.2%). 
There were 27 studies which did not report any ethnicity data. Of those that did report ethnicity, 
it varied in the depth of detail given and with the exception of three studies, the category of 
‘White’/’White British’/’Caucasian’ was the largest ethnic group. The exceptions here included 
Mofrad & Webster (2014) who reported on a case study of a woman with Middle Eastern 
ethnicity, Kuhn (2011) who reported ‘Asian’ ethnicity accounted for 34% of the included sample 
(‘White British’ accounted for 33%, and ‘White other’ accounted for 13%), and Jolley et al 
(2015) who reported ‘BME’ as representing 58% of the sample (with ‘Non-BME’ accounting for 
the rest of the sample). From the geographical region reported, the North of England represented 
the largest number of studies (with n=17 studies noting North of England sites; and n=5 noting 
North-West sites), whilst London IAPT services were the next largest group (n=11 studies). 
Other areas included IAPT services in the South of England (n=5 studies), the East and Midland 
regions (n=4 and 2, respectively), Northern Ireland where n=1 study was completed and n=4 
studies which utilised data from throughout England. 
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3.2.2 Outcome measures 
 Only two studies did not include an analysis of PHQ-9 outcomes. GAD-7 outcomes were 
reported in 54/60 studies (90%). The WSAS outcomes were reported much less frequently with 
only 21/60 studies (35%) reporting impairment outcomes. Thirty-two other outcome measures 
were used across 18/60 (30%) studies (e.g., SDSCA, a measure of diabetes self-care was utilised 
when the target condition was low mood and worry alongside T2DM (type II diabetes mellitus; 
Wroe et al., 2015). Only two studies reported on patient satisfaction (Kuhn, 2011; Jolley et al., 
2015). Due to a lack of consistent reporting of disorder-specific outcome measures across the 
studies, only the MDS measures were investigated within the meta-analysis. 
3.2.3 Mental health conditions and populations 
 The majority of studies investigated IAPT services for the conditions it was originally 
commissioned for (i.e., depression, anxiety, or related/common mental health conditions). In six 
studies (9.8%), outcomes with physical health conditions were investigated (including long-term 
conditions, medically unexplained symptoms), whilst in a further one study (1.6%) dementia was 
the clinical context. Other target conditions included psychosis, relationship distress and 
problematic alcohol use (one study each; 4.9% overall). One paper (1.6%) investigated the 
effectiveness of an IAPT service provision within a prison for male offenders (Adamson, Gibbs 
& McLaughlin, 2016), whilst two papers (3.3%) studied outcomes for military veteran-based 
services (Clarkson et al., 2016; Giebel, Clarkson & Challis, 2014). One study explored the 
effectiveness of both a generic IAPT service and one specifically aimed at British Sign Language 
(BSL) users for a deaf population (Young et al., 2017), whilst another examined any differences 
in outcomes based on reported sexual orientation of the client (Rimes et al., 2018). 
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3.2.4 Interventions and stepped care 
 The specific treatment protocols used to treat patients tended not to be reported in the 
studies, as studies tended to simply state either generic step or step 3 interventions were 
delivered.  Overall, n = 21 studies reported on interventions at either Step 2 or Step 3, whilst any 
‘Step 2’ intervention was reported in n = 11 studies, and any ‘Step 3’ intervention was reported 
in n = 1 study. Where there was a specific intervention discussed and evaluated, this ranged in 
the intensity and type. CBT was specified as the intervention in n = 6 studies (Binnie & Boden, 
2016; Branson, Shafran & Miles, 2015; Highfield et al., 2016; McDevitt-Petrovic et al., 2018; 
Pybis, Saxon, Hill & Barkham, 2017; Saxon, Firth & Barkham, 2017), with another study 
looking at those clients who had received a previous course of CBT (Ali et al., 2017), and two 
others using manuals based on CBT – one for psychosis (CBT-p) (Jolley et al., 2015) and one 
trauma-informed CBT intervention (Murray, 2017).  Five studies  investigated group 
interventions (n = 6 studies) including two using ‘Stress Control’ group intervention at step 2 
(Burns, Kellett & Donohoe, 2016; Delgadillo et al., 2016b), one high intensity behavioural 
activation group (‘BAG’) at step 3 (Kellett, Simmonds-Buckley, Bliss, & Waller, 2017), and 
another step 2 intervention for dementia patients and their carers (Cheston & Howells, 2016). 
Other single studies analysed outcomes for systemic therapy (Kuhn, 2011), dynamic 
interpersonal therapy (DIT) (Wright & Abrahams, 2015), couples’ therapy (BCT-D) (Baucom et 
al., 2018) and a guided self-help CAT intervention (CAT-SH) (Meadows & Kellett, 2017). The 
full range of interventions can be found in Table 2.
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Table 3:  Main findings and quality assessment ratings 
Author & Year Main Findings Quality score* 
(CASP) 
 
(bias range – low, 
medium, high) 
Adamson et al 
(2015) 
Clinical contacts: 82% Low-intensity; average sessions 4.5 (SD 3.06, range 2-8); 18% High-intensity, average 
sessions 7.5 (SD 6.11, range 2-20). 
Pre-treatment: 91% clinical range (PHQ) and 94% (GAD); post treatment: 55% recovered (PHQ) and 52% (GAD). 
Low 
Ali et al (2014) Clinical contacts: average sessions 5.2 (SD 2.2). 
Therapist effects minimal effect on outcomes; between-patient variability has larger impact. 
Low 
Ali et al (2017) Following low-intensity CBT treatment, 52.8% of patients experienced relapse (deterioration of symptoms to 
clinically significant levels), with 79% of those occurring within the first 6 months post-treatment. 
 
Patients with residual depression symptoms at the end of treatment (PHQ-9 scores 5-9) were more likely to relapse 
and have shorter remission times than those completing treatment without residual depression symptoms. 
Low 
Baucom et al 
(2018) 
Clinical contacts: average 10.85 (SD 6.07; range 2-26). 
Recovery (both PHQ-9/GAD-7 below caseness): full sample of clients = 57.1% recovered; in subsample (those with 
both client and partner in clinical range pre-treatment), clients = 45.2% recovered and partners = 48.4% recovered. 
Client effect sizes: PHQ-9 d = 2.23; GAD-7 d = 1.80; CSI-4 d = 0.43. 
 
Low 
Binnie & Boden 
(2016) 
Higher levels of depression significantly predicted drop-out. 
Reasons stated by patients for non-attendance included: feeling unwell (both in relation to physical and mental health 
symptoms), other priorities, relationship (with the therapist or therapy modality).  
Low 
Branson et al 
(2015) 
CBT competence, as measured by therapy session video recordings and rated using the CTS-R, was generally not 
associated with patient outcomes except in the extreme ends of competence. 
Medium 
Branson et al 
(2018) 
Patients treated by qualified PWPs showed higher rates of improvement and lower rates of deterioration than those 
treated by trainees. 
Clinical competence, as measured by the OSCE, was generally not associated with patient outcomes except in the 
extreme ends of competence. 
Medium 
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Buckman et al 
(2018) 
High alcohol consumption (as indicated by >=6 or >=8 on AUDIT-C) was not associated with treatment outcomes 
(recovery or RCSC measures). 
Scores >=8 on the AUDIT-C was associated with greater odds of dropping out of treatment. 
Low 
Burns et al 
(2016) 
Stress Control group: 
Clinical contacts = 6 total (2 hours each), 2x PWPs to run. 
Attendees = average 74 people (range n=23-106). 
 
Recovery = 47.1% recovered (when all 6 sessions attended, recovery was 59.2%) – there was a significant 
association between number of sessions attended and recovery. 
Those with depression or anxiety more likely to recover than those with comorbidity. 
 
Caseness: n=387 pre-treatment on GAD-7) - 58.9% reliably improved and 2.8% reliably deteriorated post-treatment. 
Caseness: n=302 pre-treatment on PHQ-9 - 45.4% reliably improved and 2% reliably deteriorated post-treatment. 
Low 
Chan et al 
(2014) 
Clinical contacts: Low-intensity, average sessions 6.61 (SD 3.99); High-intensity, average session 15.98 (SD 8.95). 
 
Recovery = 50% High-intensity; 55.3% Low-intensity. 
PHQ-9 post-treatment effect sizes: High-intensity d = 0.86, Low-intensity d = 0.66. 
GAD-7 post-treatment effect sizes: High-intensity d = 0.99, Low-intensity d = 0.85. 
Medium 
Cheston et al 
(2016) 
Four patients and their carers took part. 
Some improvements in Quality of Life outcome measures - 2/3 patients scores increased; 3/3 carers scores increased. 
Qualitative interviews - confirm quantitative results (in terms of the group being helpful or not). 
High 
Clark et al 
(2009) 
Recovery post-treatment = 55%. Low 
Clark et al 
(2018) 
Service organisation features predicting clinical outcomes – 
Positive associations with outcome: 
i) % of cases with a problem descriptor; ii) number of treatment sessions; iii) % of referrals. 
Negative associations with outcome: 
i) time waited to start treatment; ii) % of appointments missed. 
 
Negative associations with outcome: 
i) social deprivation of a CCG. 
Medium 
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Clarkson et al 
(2016) 
Post-treatment effect sizes (full sample, n=505): PHQ-9 d = 0.62, GAD-7 d = 0.63; WSAS d = 0.41 
Post-treatment effect sizes (completed treatment, n=156) PHQ-9 d = 1.07, GAD-7 d = 1.03, WSAS d = 0.75 
Of those at caseness pre-treatment, 33% and 30% recovered at post-treatment (PHQ-9 & GAD-7, respectively). 
Low 
Delgadillo et al 
(2014a) 
Post-treatment recovery rates: depression = 42.2%, anxiety = 43.5%. 
Post-treatment effect sizes: depression d = 0.81, anxiety d = 0.90. 
Low 
Delgadillo et al 
(2014b) 
Early improvements can predict end of treatment RCSI (even after confounds taken into account). 
Early change in treatment was a better predictor of recovery than baseline severity and pre-treatment symptom 
improvement. 
It takes at least 4 sessions to achieve >50% RCSI rates for patients accessing low-intensity interventions. 
Highest attrition rates occur in sessions 1-4. 
Low 
Delgadillo et al 
(2016a) 
Larger number of referrals were moderately associated with areas of greater deprivation. 
There was no association between deprivation and case-load size. 
Significant associations between deprivation and outcomes were found - lower recovery rates were associated with  
areas of greater deprivation. 
Using the 50% recovery target - a large proportion of services can be deemed 'underperforming' (72.5%). Whereas 
using an IMD-adjusted benchmark indicates a lower proportion are 'underperforming' (43.1%). 
Low 
Delgadillo et al 
(2016b) 
Recovery rates of those meeting caseness pre-treatment: depression = 41.0%, anxiety = 42.2%, overall = 41.6%. 
Post-treatment effect sizes: depression d = 0.59, anxiety d = 0.70, functioning d = 0.47. 
 
Low 
Delgadillo et al 
(2016c) 
PHQ-9 (depression) model classified 63.4% of sample on pre-treatment predictors of poor depression outcomes: 
- younger age, unemployment, having a self-reported disability, higher baseline WSAS scores. 
GAD-7 (anxiety) model classified 62.1% of sample on pre-treatment predictors of poor anxiety outcomes: 
- higher baseline depression scores (PHQ-9), low treatment outcomes expectations. 
Leeds Risk Index (LRI) developed based on predictors of poorer outcomes. 
Low 
Delgadillo et al 
(2017a) 
Demographics and outcome measures: 
age - weak association; gender - no association; unemployment - higher distress at post-treatment correlated with 
unemployment; ethnicity - higher post-treatment outcomes in non-White patients; deprivation (living area) - higher 
post-treatment scores associated with more deprived socioeconomic area. 
 
Long-term conditions (LTCs): 
Five LTCs were associated with higher post-treatment scores (controlling for demographics and clinically relevant 
information). 
People with LTCs are more likely to be offered High-intensity interventions. 
Low 
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Delgadillo et al 
(2017b) 
Depression prognostic model: 
Demographic characteristics explained more variance in post-treatment RSCI outcomes (22.5%) relative to clinical 
characteristics (15%) and personality features (14.7%). 
Anxiety prognostic model: 
Clinical characteristics explained more variance in post-treatment RCSI outcomes (55.9%) relative to personality 
features (23.9%) and demographic characteristics (15.2%). 
 
Complex cases were more likely to obtain poorer outcomes after treatment. 
Those complex cases assigned to High-intensity treatment initially (rather than assigned to Low-intensity and then 
stepped up to High-intensity) were more likely to show RCSI (PHQ-9 only; GAD-7 approaching significance). 
Low 
Delgadillo et al 
(2017c) 
Patients in the 'OF' cohort had shorter average duration of treatment and lower average cost of treatment episode. 
Patients in 'controls' cohort more likely to be described as 'not-on-track' (NOT). 
No significant differences in outcomes by both cohorts ('controls' and 'OF') - pre-post IAPT MDS scores. 
Qualitative interviews - OF influenced therapists use of outcome data in several ways (e.g.,): 
- discussed outcome data more consistently with patients; 
- prioritised 'NOT' patients in supervision. 
Low 
Elison et al 
(2017) 
Post-treatment effect sizes (Pearsons r): 
Breaking Free Online (substance misuse treatment) - d = 0.63 (depression); d = 0.60 (anxiety); d = 0.51 
(functioning). 
Living Life to the Full Interactive (low mood, stress, anxiety treatment) – d =0.73 (depression); d = 0.73 (anxiety); d 
= 0.47 (functioning). 
Sleepio (insomnia treatment) – d = 0.78 (depression); d = 0.69 (anxiety); d = 0.54 (functioning). 
Significant reductions in those at clinical thresholds on the outcome measures at post-treatment in all eTherapy 
programmes. 
Low 
Firth et al 
(2015) 
Post-treatment effect sizes: 
PHQ-9 d = 0.82; GAD-7 d = 0.90; WSAS d = 0.60 
RCSI post-treatment: 
PHQ-9 = 32%; GAD-7 = 36%. 
Reliable deterioration post-treatment: 
PHQ-9 = 3%; GAD-7 = 5% 
Low 
Giebel et al 
(2014) 
Post-treatment effect sizes:  
PHQ-9 d = 0.63; GAD-7 d = 0.63; WSAS d = 0.40. 
Low 
Goddard et al 
(2015) 
Patients with higher SAPAS scores (indicating the likely presence of ‘personality disorder’) were more likely to have 
poorer outcome measure scores at post-intervention for depression, anxiety and functioning. Recovery rates were 
also lower in the group with higher SAPAS scores. 
Low 
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Green et al 
(2014) 
Therapist effects: 
PHQ-9 outcomes = 8.7%; GAD-7 outcomes = 8.8% - i.e., variability in patient outcomes is due to variability 
between PWPs. 
Post-treatment effect sizes:  
PHQ-9 d = 0.52; GAD-7 d = 0.55 
Comparisons of effect sizes from lowest ranked and highest ranked PWPs: 
Lowest ranked - PHQ d = 0.20, GAD d = 0.22 
Highest ranked - PHQ d = 0.92; GAD d = 0.95. 
 
Low 
Griffiths et al 
(2014) 
Post-treatment effect sizes on those who: 
i) scored severe on the PHQ-9 at screening: PHQ-9 d = 0.52, GAD-7 d = 0.40, WSAS d = 0.30. 
ii) scored severe on the GAD-7 at screening: PHQ-9 d = 0.45, GAD-7 d = 0.55, WSAS d = 0.30. 
iii) scored severe on the WSAS at screening: PHQ-9 d = 0.37, GAD-7 d = 0.32, WSAS d = 0.49. 
iv) scored severe on all measures at screening: PHQ-9 d = 0.46, GAD-7 d = 0.42, WSAS d = 0.44. 
 
Medium 
Gyani et al 
(2013) 
40.3% of sample showed reliable recovery (range between services: 23.9% to 56.5%). 
6.6% of sample showed reliable deterioration (range between services: 2.1% to 11.4%). 
Compliance with NICE guidelines (recommendation of CBT for depression and GAD; counselling for depression) 
resulted in higher recovery rates (high intensity treatment). 
Those receiving guided self-help (compared with those receiving non-guided self-help) had higher recovery rates 
(low intensity treatment). 
Factors predicting reliable recovery included: patient-level (e.g., initial severity) and service-level (e.g., number of 
sessions, size of service). 
Low 
Hammond et al 
(2012) 
In general, both OTT and F2F intervention conditions are effective for those attending low-intensity interventions 
within IAPT services - on measures of depression, anxiety and functioning. 
Only those with in an older age bracket and those with more severe symptoms were more likely to benefit from F2F. 
Costings: 
F2F mean session cost = £119; OTT mean session cost = £79. 
Low 
Highfield et al 
(2016) 
Step 2: 
Significant improvement from pre to post treatment on PHQ-9, GAD-7 and self-efficacy scale. 
Post-treatment recovery: 35.71%. 
Step 3: 
Post-treatment recovery - non-trained workers: depression = 58%; anxiety = 54%. 
Post-treatment recovery - trained workers: depression = 79%; anxiety = 90%. 
High 
Jolley et al 
(2015) 
Clinical contacts: completers = 15.6 (SD 7.4); drop-out = 2.8 (SD 1.1). 
Post-treatment effect sizes: 
CHOICE: d = 0.7 (completers), d = 0.2 (drop-out). 
WSAS d = 0.4. 
Satisfaction ratings - mean score 8.2 (range 6-17, lower scores more favourable). 
 
Medium 
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Kellett et al 
(2016) 
Post-treatment effect sizes (Partial eta squared): 
Long-term condition – PHQ-9 d = 0.35, GAD-7 d = 0.32 
Medically-unexplained symptoms – PHQ-9 d = 0.25, GAD-7 d = 0.31 
 
Low 
Kellett et al 
(2017) 
Post-treatment effect sizes: 
PHQ-9 d = 0.73; GAD-7 d = 0.49; WSAS d = 0.52 
Low 
Kenwright et al 
(2017) 
Clinical contacts: 
BCA - 7.2 hours (SD 5.8); Non-BCA - 6.9 hours (SD 5.5). 
Step: 
BCA - 79% received step 3/high-intensity treatment (CBT therapist); Non-BCA - 63% received step 3/high-intensity 
treatment (CBT therapist) (non-significant difference). 
Pre-treatment to 6-month follow-up effect sizes: 
BCA – PHQ-9 d = 2.0, GAD-7 d = 2.2. 
Non-BCA - PHQ-9 d = 1.8, GAD-7 d = 2.4. 
IBS scale - total: d = 2.0; BCA showed greater improvement than non-BCA at 6-month follow-up. 
 
Low 
Kuhn (2011) Clinical contacts: average sessions = 8 (SD 4.9). 
Post-treatment effect sizes: 
PHQ-9 d = 1.28, GAD-7 d = 1.15, CORE-OM (distress) d = 1.29. 
Client satisfaction: 
Therapy clients were 97% mostly/very satisfied with the service; and 92% satisfied with the choice about treatment. 
High 
Lucock et al 
(2018) 
Remission (<10 on PHQ-9): 
86% of patients were in remission by the third contact (telephone call; final point) vs. 60% in remission at the first 
session. 
Medium 
Luik et al 
(2017) 
Post-treatment recovery: n=48 (68%). 
Insomnia symptoms significantly decreased. 
Medium 
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Matthew Prina 
et al (2014) 
Over 65-year olds accounted for 4% of referrals in the 6 PCTs in the East of England during the study period. 
Older age (over 65-years) was associated with a shorter wait from referral to assessment and from referral to first 
treatment session. 
In general, older age was associated with higher recovery rates however this was largely non-significant. 
Low 
McDevitt-
Petrovic et al 
(2018) 
Depression: 
Reliable improvement = 59.5% of patients; Reliable deterioration = 3%. 
Anxiety: 
Reliable improvement = 70.6% of patients; Reliable deterioration = 5.5%. 
Overall: 
Reliable recovery: 47.9%; Reliable improvement = 76.7% of patients; Reliable deterioration = 6.1%. 
Medium 
Meadows et al 
(2017) 
Post-treatment effect size: 
PHQ-9 d = 1.27, GAD-7 d = 1.66, WSAS d = 1.28. 
Low 
Methley et al 
(2016) 
Some changes on outcome measures were reported post-intervention in relation to depression, anxiety and PTSD 
although in general participation in the treatment group on these symptoms was deemed to be inconclusive. 
Medium 
Mofrad et al 
(2014) 
Subjective reports - positive outcomes reported. 
IAPT MDS - mixed sessional outcomes over the treatment, with a general decline (although no means/SDs given). 
High 
Morrison et al 
(2014) 
Recovery: 
PHQ-9 – 70% (n = 10). 
Medium 
Murray (2017) Following the training programme for therapists, significant differences in the outcomes on the IES-R were reported 
but not on the PHQ-9 or GAD-7. Those patients treated after the training programme had significantly lower scores 
on the IES-R than those patients treated before the training programme. 
High 
Pack et al 
(2014) 
RSES (self-esteem measure) - clinical and significant change pre-post treatment only. 
PHQ-9 - clinical and significant change pre-post treatment; clinical and significant change at pre- to 3-month follow-
up. 
GAD-7 - clinical and significant change pre-post treatment; clinical and significant change at pre- to 3-month follow-
up. 
Medium 
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Pereira et al 
(2016) 
Therapist effect of 6.7% based on patient depression scores. 
Higher levels of mindfulness, resilience and the two combined were found in those deemed more effective therapists 
than those deemed less effective therapists. 
Medium 
Pettit et al 
(2017) 
Those in younger age bands (20-24 years, 25-29 years) were more likely to be referred to IAPT services for common 
mental health difficulties. 
Lowest attendance rates were found in younger age bands (20-24 years, 57.34% attendance) compared to older age 
bands (60-64 years, 76.97% attendance). 
MCID or reliable improvement increases throughout the age bands (from 20-24years through to 65-69 years), with 
the lowest rates being in those 70-74 years. 
Medium 
Poots et al 
(2014) 
Those from higher areas of deprivation were significantly more likely to have higher baseline depression scores. 
There was no significant difference in the change scores on the depression measure between levels of deprivation. 
Inequity of service by deprivation level is not supported. 
High 
Pybis et al 
(2017) 
Clinical contacts: 
Overall average sessions = 8.5 (SD 6.18); CBT sessions = 8.9 (SD 6.34); Counselling sessions = 7.5 (SD 5.54). 
Post-treatment effect size: 
CBT d = 0.94 (95% CI 0.92-0.95). 
Counselling d = 0.95 (95% CI 0.92-0.98). 
Low 
Radhakrishnan 
et al (2013) 
Clinical contacts: 
Of those patients who attended 2+ sessions, 44.9% completed treatment, 18.2% dropped out. 
Costings: 
Across all sites, average cost per session of Low-intensity = £98.59 (range £78.31 - £150.17); average cost of High-
intensity = £176.97 (range £140 - £270.41). 
Cost per recovered client: 
Across all sites, average cost of any step £1766 (with assessment). 
Low-intensity, average cost of recovery £1043 (with assessment). 
High-intensity, average cost of recovery £2895 (with assessment). 
Cost per completed treatment: 
Across all sites, average cost of completed treatment £877. 
Low 
Richards et al 
(2011) 
Clinical contacts: 
Average number of sessions = 5.49 (SD 4.31) 
Average number of face-to-face contacts = 2.33 (SD 2.96) 
Average number of telephone contacts = 3.17 (SD 3.01). 
Post-treatment effect size: 
PHQ-9 d = 1.07 (0.88-1.29); GAD-7 d = 1.04 (0.88-1.23). 
 
Low 
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Rimes et al 
(2018) 
Changes in symptomatology outcomes (when controlling for potential confounding factors): 
Females - Smaller change scores for depression (PHQ-9) and functioning (WSAS) were reported in those who 
identified as lesbian or bisexual compared to those who identified as heterosexual; smaller change scores for anxiety 
(GAD-7) was reported in those who identified as bisexual compared to those who identified as heterosexual. 
Males - no significant differences across sexuality groups. 
 
'Failure to recover' (when controlling for potential confounding factors): 
Females - 64.9% (lesbian women), 75.2% (bisexual women), 61.3% (heterosexual women) 'failed to meet recovery'. 
This same pattern, albeit slightly higher, was found in the analyses investigating 'failure to meet reliable recovery'. 
Significant differences were reported between bisexual women and heterosexual women only. 
Males - 58.1% (gay men), 64.0% (bisexual men), 59.5% (heterosexual men) 'failed to meet recovery'. This same 
pattern, albeit slightly higher, was found in the analyses investigating 'failure to meet reliable recovery'. Logistic 
regression analyses were non-significant. 
Low 
Saunders et al 
(2016) 
Latent profiles for groups of patients based on similar characteristics were generated. 
Examples include: 
- those with low symptomatology baseline scores (anxiety & depression) plus high functioning in everyday life are 
high likelihood of achieving recovery (74% - brief intervention) in comparison to the full dataset (40%). 
- those with higher symptomatology baseline scores (anxiety & depression) plus low functioning in everyday life 
have a lower likelihood of achieving recovery (11% - brief intervention) in comparison to the full dataset. 
Low 
Saxon et al 
(2017) 
A therapist effect of 5.8% was reported, with those therapists rated 'more effective' showing higher recovery rates in 
the patients that they treated (compared to 'less effective' therapists). 
Patient outcomes improved with additional sessions, in general. 
Low 
Scott (2018) Post-treatment recovery rates: 
Depression (n = 26) – recovery = 21.3%, reliable improvement = 11.5%. 
Anxiety (n = 26) - recovery = 46.0%, reliable improvement = 11.5%. 




Factors compared at time 1 ("high recovery") and time 2 ("low recovery”): 
- wait to triage - on average longer wait at time 2 (11 days at step 2; 9 days at step 3). 
Recovery rates and associated factors: 
- baseline symptom severity was associated with recovery (i.e., those who recovered were more likely to have lower 
starting BL severity). 
- number of treatment sessions, i.e., more sessions were completed by those who recovered at time 1 & 2 (an average 
of >=2 sessions at step 2/low-intensity with a similar pattern found at step 3/high-intensity). 
Medium 
Wright et al 
(2015) 
Post-treatment effect size: 
PHQ-9 d = 0.46. 
GAD-7 d = 0.52. 
Medium 
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Wroe et al 
(2015) 
Adaptations can be made to Step 2/low-intensity interventions within IAPT to support those with comorbid LTCs 
(specifically, T2DM). 
Medium 
Young et al 
(2017) 
BSL cut-offs used for recovery for IAPT-BSL; standard cut-offs used for IAPT generic BSL clients. 
BSL cut-offs: PHQ = 8 (standard = 10), GAD = 6 (standard = 8). 
Post-treatment recovery rates: 
Recovered – generic IAPT = 41.2%, BSL-IAPT = 43.0% 
Not recovered – generic IAPT = 58.8%, BSL-IAPT = 57.0% 
Post-treatment reliable improvement rates: 
Reliably improved - generic IAPT = 63.5%, BSL-IAPT = 66.8 
No reliable change - generic IAPT = 32.9%, BSL-IAPT = 27.2% 
Reliably deteriorated - generic IAPT = 3.5%, BSL-IAPT = 6.0 
Medium 
*Quality score – more information can be found in the appendix. 
Reported effect sizes are Cohen’s d unless otherwise stated. 
 
Key: CTS-R = Cognitive Therapy Scale Revised; PWPs = Psychological Wellbeing Practitioners; OSCE = Observed Standardised Clinical Examination; CSI-4 = Couples Satisfaction 
Index (4-item); AUDIT-C = Alcohol Use Disorders Identification Test-Consumption; CORE-OM = Clinical Outcomes in Routine Evaluation-Outcome Measure; SAPAS = Standardised Assessment of 
Personality – abbreviated scale; CHOICE = Choice of outcome in cognitive therapy for psychoses; IES-R = Impact of Events Scale – Revised; RSES = Rosenberg’s Self-Esteem Scale; OTT = Over the 
telephone; FTF = face-to-face; CCG = Clinical Commissioning Groups; PCTs = Primary Care Trusts; BSL = British Sign Language; PTSD = Post-traumatic stress disorder; T2DM = Type 2 Diabetes Mellitus; 
GAD = Generalised Anxiety Disorder; BCA = Bowel Control Anxiety; IAPT MDS = Improving Access to Psychological Treatment Minimum Dataset; RSCS = Reliable and Clinically Significant Change; RCSI = 
Reliable and Clinically Significant Improvement; MCID = Minimal Clinical Importance Difference; IMD = Index of Multiple Deprivation; OF = Outcome Feedback. 
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3.3 Meta-analysis 
 Overall, n=47 studies were included in the meta-analysis. The analyses were organised 
according to the outcome measures routinely used within IAPT services. Due to discrepancies 
with which measures were used within each study, this created different numbers in each 
analysis. Within the studies included here, 46 used the PHQ-9 as an outcome measure; 41 used 
the GAD-7 as an outcome measure; 19 used the WSAS as an outcome measure. Some of the 
included studies reported more than one effect size (ES) for independent samples contained 
within their original research (n = 8 studies). Where this occurred and the separate ES reported 
did not contain overlapping patient data, the effect sizes were included as independent samples. 
This was consistently implemented across the whole meta-analysis and subgroup analyses. For 
example, in the paper by Delgadillo et al. (2017a) separate ES are reported for different patient 
groups and therefore each group is represented by the individually reported ES. This means that 
whilst the number of studies is given in each description below, this does not always match the 
actual number in the ES calculations included in the meta-analysis. The number of studies and 
number of ES reported in each analysis will be reported for clarity.  A very limited number of 
studies also include follow-up data (n = 4; Clark et al, 2009; Kenwright, McDonald, Talbot & 
Janjua, 2017; Meadows & Kellett, 2017; Pack & Condren, 2014). Due to the small number of 
these studies, follow-up outcomes have not been included within this meta-analysis. 
 
3.3.1 Primary meta-analysis 
 Results for the PHQ-9 summarizing outcomes from 636,734 patients (mean n = 9796; 
median n = 619) across 46 studies (n = 65 independent samples) are reported in Figure 2. The 
overall combined pre-post treatment PHQ-9 effect size was large (d = 0.87, 95% CI [0.78-0.96], 
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p<.0001, number needed to treat [NNT]=2.17), indicating a statistically significant and large 
reduction in depression severity. 
There was evidence of considerable heterogeneity across PHQ-9 outcome studies: I2 = 
98%; Q(df = 64) = 3600.47, p<.0001. Funnel plot asymmetry (see Figure 3) suggested the 
presence of publication bias. However, there was a non-significant rank correlation test (p=.196) 
and non-significant regression test for funnel asymmetry (p=.083). The fail-safe N analysis 
indicating the number of non-significant studies likely needed to be published to reduce the 
findings to a small clinically non-significant effect (d = 0.35) was 97. 
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Figure 2: Forest plot of pre-post PHQ-9 independent samples effect sizes and the pooled 
treatment effect. 
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Figure 3: Funnel plot of the distribution of studies reporting pre-post PHQ-9 outcomes 
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Results for the GAD-7 included outcomes from 598,166 patients (mean n = 9969; median 
n = 541) across 41 studies (n = 60 independent samples) are reported in Figure 4. The overall 
combined pre-post treatment GAD-7 effect size was large (d = 0.88, 95% CI [0.79-0.97], 
p<.0001, NNT=2.15), indicating a statistically significant and large reduction in anxiety severity.  
There was evidence of considerable heterogeneity across studies (I2 = 98%; Q(df = 59) = 
4239.30, p<.0001). There was some evidence of funnel plot asymmetry (see Figure 5); the funnel 
plot asymmetry regression test (p=.014) and the rank correlation test (p=.008) were significant 
indicating there may be some publication bias. However, the fail-safe N analysis indicated that 
92 studies with null findings would be necessary to reduce the results to clinically non-
significant. The results for the WSAS included data from 478,693 patients (mean n = 19,946; 
median n = 1351) from 19 studies (n = 24 independent samples) and are summarized in Figure 6.  
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Figure 4: Forest plot of pre-post GAD-7 independent samples effect sizes and the pooled 
treatment effect.
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Figure 5: Funnel plot of the distribution of studies reporting pre-post GAD-7 outcomes. 
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The overall combined WSAS effect size was moderate (d = 0.55, 95% CI [0.48-0.61], 
p<.0001, NNT=3.30), indexing a statistically significant treatment effect on work and social 
adjustment.  
There was evidence of considerable significant heterogeneity across studies (I2 = 95%; 
Q(df = 23) = 524.11, p<.0001). Funnel plots were visually inspected and suggested some 
asymmetry with missing studies demonstrating larger effects (see Figure 7). The statistical tests 
showed mixed evidence of publication bias; the funnel plot asymmetry regression suggested 
significant asymmetry (p=.027) and the fail-safe N indicated 13 null-finding studies would 
reduce the average effect size to a small clinically non-significant pre-post improvement (d = 
0.35), however the rank correlation test was not significant (p=.572). 
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Figure 6: Forest plot of pre-post WSAS independent samples effect sizes and the pooled 
treatment effect.
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Figure 7: Funnel plot of the distribution of studies reporting pre-post WSAS outcomes. 
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Moderator and sensitivity analyses  
Subgroup analyses of categorical variables.  
Significant between-study heterogeneity was explored using subgroup analyses to investigate 
five categorical moderators of treatment effects across the three outcomes (Table 4). For PHQ-9 
outcomes, significant variations in effect sizes by subgroups were evident for type of 
methodology used, primary condition, step of care and level of study bias. Completer analysis 
produced significantly larger effect sizes than ITT and studies of primary mental health 
conditions produced significantly larger effects than studies with physical health as the primary 
condition. Studies with increased levels of bias produced larger treatment effects than studies 
with less influence of bias and step 3 produced larger effects than step 2, however the subgroup 
differences in both comparisons were no longer significant after accounting for multiple testing. 
For GAD-7 outcomes, significant variations in effect sizes by subgroups were evident for type of 
methodology used , primary condition and level of study bias, showing the same pattern as in the 
PHQ-9 outcomes; significantly larger effects for completer analysis versus ITT, for treatment of 
primary mental health conditions versus physical health conditions and in studies with higher 
levels of bias. Effects for step of care were not significantly different for GAD-7 outcomes. The 
format of treatment did not explain variations in treatment effects for either PHQ-9 or GAD-7 
outcomes and no significant variation in effects across subgroups were found for WSAS 
outcomes.
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Table 4: Subgroup analysis of pre-post treatment effects 
 
Outcome Variable Subgroup k 
Effect 
size 





PHQ-9  Methodology ITT 43 0.78 0.67 to 0.90 99% 5701.68*** .001** 
 COM 22 1.04 0.97 to 1.12 98% 3128.89***  
 Study bias Low 44 0.82 0.71 to 0.93 99% 5576.75*** .016* 
  Medium 17 0.95 0.84 to 1.06 99% 4043.44***  
  High  4 1.26 0.96 to 1.56 77% 13.16**  
 Primary condition Mental health 52 0.94 0.87 to 1.01 99% 9080.97*** .001** 
 Physical health 10 0.43 0.13 to 0.74 94% 170.82***  
 Step of care Step 2 only 15 0.80 0.68 to 0.93 97% 686.96*** .038* 
  Step 3 only 9 1.09 0.85 to 1.33 93% 120.46***  
 Format Individual  38 0.77 0.65 to 0.89 99% 5194.26*** .500 
  Group 6 0.88 0.59 to 1.16 92% 69.92***  
GAD-7 Methodology ITT 41 0.80 0.68 to 0.91 99% 5484.73*** <.001** 
 COM 19 1.06 0.98 to 1.14 99% 3967.79***  
 Study bias  
 
Low 41 0.83 0.72 to 0.94 98% 3655.71*** .001** 
 Medium 16 0.97 0.84 to 1.09 99% 5223.23***  
  High  3 1.36 1.10 to 1.62 24% 2.63  
 Primary condition Mental health 47 0.96 0.88 to 1.04 99% 10813.46*** .006** 
 Physical health 10 0.50 0.19 to 0.82 94% 175.50***  
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 Step of care Step 2 only 14 0.88 0.74 to 1.03 98% 776.13*** .182 
  Step 3 only 6 1.16 0.77 to 1.56 84% 32.46*  
 Format 
 
Individual 33 0.76 0.62 to 0.89 99% 4782.75*** .291 
 Group 6 0.91 0.66 to 1.16 93% 73.78**  
WSAS1 Methodology ITT 21 0.54 0.48 to 0.61 98% 1236.70*** .154 
  COM 3 0.44 0.32 to 0.57 0% 0.74  
 Study bias Low 19 0.55 0.48 to 0.62 97% 780.55** .389 
  Medium 5 0.48 0.34 to 0.62 99% 810.32***  
 Step of care Step 2 only 7 0.52 0.43 to 0.61 98% 432.12*** .239 
  Step 3 only 2 0.44 0.33 to 0.55 0% 0.18  
 Format Individual 12 0.48  0.41 to 0.55 98% 916.96 .930 
  Group 2 0.48 0.45 to 0.51 0% 0.87  
*significant at p < .05 threshold; **significant at  p < .01 threshold, ***significant at  p < .0001 threshold, between subgroup differences 
significant at Bonferroni adjusted p<.01 threshold for multiple testing; *1 Moderator analysis for ‘primary condition’ was not undertaken for 
the WSAS outcome measure as all studies included were deemed to be investigating mental health with none focusing purely on physical health. 
Abbreviations: k: number of comparisons per subgroup, CI: confidence interval, PHQ-9: Patient Health Questionnaire-9, GAD-7: Generalized 
Anxiety Disorder scale-7; WSAS; Work and social adjustment scale; ITT: Intention to treat; COM; completer.
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Meta-regression analyses of continuous variables.  
Significant between-study heterogeneity was explored using meta-regressions to 
investigate four continuous moderators of treatment effects across the three outcomes (Table 5). 
For GAD-7 and WSAS outcomes, between-study variations in effect sizes were not related to 
differences in the mean age or gender proportions of the study samples. PHQ-9 outcomes did 
show larger treatment effects when proportions of males increased, however the effect did not 
remain significant after adjusting for multiple testing. Mean treatment duration was significantly 
associated with between-study effect size variations for both PHQ-9 and GAD-7 outcomes, with 
larger effects evident when there was a greater mean number of sessions attended. Larger effects 
were also associated with higher baseline severity scores for PHQ-9 and GAD-7 outcomes 
(although the PHQ-9 effect did not remain significant after accounting for multiple testing. There 
was no association between intake score or treatment duration and variation in treatment effects 
for WSAS outcomes.
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Table 5: Meta-regression analysis of pre-post treatment effects 
 
Note: *significant at p < .05 threshold; **significant at  p < .01 threshold, ***significant at  p < .0001 threshold, significant at Bonferroni 
adjusted p<.01 threshold for multiple testing; Abbreviations: k: number of comparisons, CI: confidence interval; SE: standard error; M: mean; 
PHQ-9: Patient Health Questionnaire-9, GAD-7: Generalized Anxiety Disorder scale-7; WSAS; Work and social adjustment scale.
Outcome Variable Range and mean k 
B-
coefficient 
95% CI SE p 
PHQ-9  Gender (% female) (0 – 100%; M=59.5) 52 -0.00 -0.01 to 0.00 0.00 .034* 
Mean age (31 – 49 years; M=39.8) 45 -0.01 -0.03 to 0.00 0.01 .131 
 Mean intake score (7.9 – 18.8; M=15.0) 58 0.02 0.00 to 0.04 0.01 .015* 
 Mean number of sessions (3 – 16 sessions; M=6.7) 42 0.03 0.01 to 0.05 0.01 .001** 
GAD-7 Gender (% female) (0 – 100%; M=59.1) 49 0.00 0.00 to 0.00 0.00 .079 
Mean age (31 – 49 years; M=39.7) 43 -0.01 -0.03 to 0.00 0.01 .061 
 Mean intake score (3.7 – 18.3; M=13.5) 52 0.07 0.04 to 0.09 0.01 <.001*** 
 Mean number of sessions (3 – 16 sessions: M=6.6) 38 0.03 0.01 to 0.05 0.01 .015* 
WSAS Gender (% female) (0 – 100%; M=54.9) 22 0.00 0.00 to 0.00 0.00 .283 
 Mean age (31 – 49 years; M=39.3) 20 0.00 -0.02 to 0.02 0.01 .689 
 Mean intake score (14.8 – 24.5; M=19.3) 22 -0.01 -0.05 to 0.04 0.02 .751 
 Mean number of sessions (4 - 16 sessions; M=6.7) 18 0.02 -0.01 to 0.05 0.01 .163 
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Sensitivity analysis excluding atypical studies.  
Sensitivity analyses investigated the aggregated effect size for those studies that were 
more similar to each other, through excluding studies deemed to be atypical of routine IAPT 
services in terms of their population, target condition or treatment type. There were 8 studies 
excluded on this basis. The excluded studies focused on samples of: male offenders (Adamson et 
al, 2015), two studies of veterans (Clarkson et al, 2016; Giebel et al, 2014), deaf patients (Young 
et al, 2017), two studies of systemic therapy (Kuhn, 2011; DIT, Wright et al, 2015) and two 
studies due to both the population and treatment delivered (couples and BCT-D, Baucom et al, 
2018; psychosis and CBT-p, Jolley et al, 2015). Meta-analyses for each outcome were re-run 
with the atypical studies excluded. Overall, and in comparison, to the primary meta-analysis of 
all studies, there was minimal difference in the ES from the sensitivity analysis. With regards to 
the PHQ-9, 57 separate comparisons contributed to the analysis producing a moderate to large 
ES of d = 0.85 (95% CI [0.80 to 0.90]; p<.0001, NNT=2.19). There was evidence of 
considerable heterogeneity across studies (I2 = 98%; Q(df = 56) = 3557.37, p<.0001). The GAD-
7 pooled ES was calculated from 52 typical studies and still indicated a large effect (d = 0.87, 
95% CI [0.81 to 0.94]; p<.0001, NNT=2.17) with large between-study heterogeneity (I2 = 98%; 
Q(df = 51) = 4201.15, p<.0001). Twenty-one comparisons contributed to the WSAS pooled ES, 
producing a moderate effect (d = 0.56, 95% CI [0.48 to 0.62]; p<.0001, NNT=3.25) with 
considerable heterogeneity still evident between studies (I2 = 96%; Q(df = 20) =523.88, 
p<.0001). The moderator analyses were repeated in the typical study sample finding similar 
effects to the main analysis (see Appendix 5). 
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3.3 Quality assessment 
 The CASP tool was used to assess the quality of included studies. The summary results 
for methodological quality can be found in Table 3 (full results can be found in Appendix 3). 
Overall, more than half of studies within this review had low risk of bias (58%) and a smaller 
percentage indicated medium (30%) or high (12%) levels of bias. Just under half of studies either 
failed or could not be identified as having identified confounding factors within the 
design/analysis and did not take such factors into account. Whether the article findings fitted 
with other available evidence was difficult to assess or inconclusive in almost half of studies. 
The studies rated as having high risk of bias tended to be studies focused on areas outside 
of mainstream IAPT (e.g., Cheston & Howells 2016). The quality of the evidence base was 
affected by the dearth of studies capturing follow-up outcomes for IAPT services. The most 
common sources of bias in the reviewed studies related to whether confounding factors within 
the study was not only reported, but also taken into account during analysis, as well as whether 
the study results were subject to follow-up. Around one-third of the included studies either did 
not discuss factors that could have influenced the results or did not take them into account within 
the analysis. This was particularly evident in those studies using completer analysis as 
differences between profiles of those participants who completed the therapy and those who 
were classed as dropping out were not adequately compared or discussed. In some studies, there 
were issues with confounding variables and difficulties ascertaining whether or not these had 
been taken into account in the analysis. Furthermore, only a minority of studies completed 
follow-up analysis. In four studies follow-ups were achieved, although in one of those studies it 
was deemed that the follow-up period was not adequately long enough. Further work in this area 
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would identify whether the outcomes achieved within the literature was maintained once therapy 
had ended, and for how long. 
4. Discussion 
This systematic review has identified and synthesized all available, peer reviewed, 
practice-based evidence generated within the UK’s IAPT programme – an initiative originally 
designed to increase rapid access to evidence-based psychological treatments for those 
experiencing common mental disorders (Clarke et al, 2009; Clarke, 2011). The narrative review 
summarised n=60 studies that varied markedly in terms of the methods used, samples studied 
and outcomes analyzed.  The meta-analysis aimed to quantify the overall impact of IAPT 
interventions standardized outcome measures, including data from over 600,000 patients. The 
exclusion of RCTs was based on a rationale of wanting to focus solely on outcomes achieved in 
routine practice, due to the common issues regarding generalizing from experimental studies to 
routine service delivery contexts (Lorenzo-Luaces, Johns, & Keefe, 2018).   
The main findings from the primary meta-analysis found a large pre-post ES for both 
reductions in depression and anxiety, with a medium ES regarding improvements in work and 
social adjustment. The GAD-7 ES mirrors the results of the Stewart and Chambless (2009) meta-
analysis of the effectiveness of CBT for adult anxiety disorders delivered in routine practice, 
which illustrated that pre-post outcomes on disorder-specific measures were large, and when 
benchmarked against the outcomes achieved in RCTs were equivalent.  The PHQ-9 ES results 
mirror the Thimm and Antonsen (2014) meta-analysis of the treatment of depression in routine 
practice in that the ES at post-treatment was large (d = .97), and at post-treatment 44% 
demonstrated a significant improvement in depression.  The tests of heterogeneity throughout the 
current meta-analyses indicated high levels of variability across studies and there was some 
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evidence of publication bias (for GAD-7 outcomes) so results should be interpreted cautiously. 
The ES reported here therefore compliment the recovery rates that are routinely submitted by 
IAPT services (Clark et al. 2019) to assess the effectiveness of the IAPT programme (alongside 
other targets related to wait-times for assessment, entry into treatment, return to work rates, etc). 
4.1 Subgroup analyses 
Studies using intention-to-treat (ITT) analyses were compared with completer analyses (COM). 
This is an important methodological distinction, due to resultant differences in those included 
participants whose data is analyzed (Kyrios, Hordern, & Fassnacht, 2015). ITT methods are 
recommended to minimise bias (Ranganathan et al, 2016), whereas COM tends to increase the 
rate of Type I errors (Fergusson, 2002). The ES for COM studies were larger than those using 
ITT across both anxiety and depression outcomes, and this is further compelling evidence that 
study designs which employ COM approaches for routinely delivered psychological 
interventions risk yielding overoptimistic and biased results.   
Significant differences were found in the magnitude of ES observed at low and high 
intensity treatments for depression (albeit no longer significant after accounting for multiple 
testing). Although differences between low and high intensity were not significant for anxiety 
outcomes and functional impairment, there was a pattern of larger ES for high intensity 
interventions. This may have been due to the fact that when intake scores were assessed, there 
were no differences in symptom levels between step 2 and step 3 studies.  PWPs are trained to 
post graduate certificate level via a national curriculum to work with mild-to-moderate anxiety 
and depression, with the psychoeducational approaches used being originally designed for such 
presentations (Kellett et al. 2020).  Therefore, ES may be being suppressed at step 2 because 
PWPs are working with presentations that are too complex for the skill level of the practitioner 
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or the content of the intervention. This finding is a challenge to stepped care principles, as low 
intensity interventions are not assumed to be less effective, just less intense in format and more 
flexible in terms of service delivery method (Firth et al. 2015). Patients deemed ‘complex cases’ 
and accessing high intensity interventions directly show better outcomes than those accessing the 
low intensity treatments and then being stepped-up to high intensity interventions (Delgadillo, 
Morea & Lutz, 2016c; Delgadillo, Huey, Bennett & McMillan, 2017b). Other research has also 
investigated the use of predictive models to identify factors that may impact on outcomes at the 
various steps of IAPT – both at patient (e.g., demographic and clinical factors) and therapist 
levels (e.g., Delgadillo, Morea & Lutz, 2016c; Firth et al, 2015). The average duration of IAPT 
treatments (mean = 6.7) was associated with larger treatment effects for depression and anxiety 
outcomes (although anxiety effects were not significant after controlling for multiple testing). 
This finding is in line with national evidence that suggests the average length of an IAPT 
treatment is 7 sessions and that patients that move to recovery attend 8 sessions on average (NHS 
Digital, 2019). 
4.2 Study limitations 
  There are some limitations within this systematic review and meta-analysis that should 
be considered when interpreting the above results. The absence of any control comparators 
across studies means that the reported pre-post effect sizes are likely to be influenced by 
statistical artefacts such as regression to the mean and also natural recovery (Posternak & Miller, 
2001; Whiteford et al., 2013). Therefore, the magnitude of effects reported in the meta-analysis 
could be overestimating the “true effect” of routinely delivered psychological interventions. 
Furthermore, the exclusion criteria imposed in the systematic searches could have further 
restricted the potential for studies to be included. For example, there are many examples of 
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evaluation work completed that does not get reported in peer-reviewed scientific journals, such 
as in the ‘grey’ literature including clinical audits and service evaluation projects. However, the 
funnel plots produced using meta-analysis did not provide evidence of publication bias. As IAPT 
produces monthly and bi-annually reports with outcome measure data, it is possible that there 
was some overlap between studies regarding patient outcome data. This was minimised as much 
as possible, such as through the exclusion of studies where the data is presented in an earlier 
publication. However, this can only be minimised and not completely excluded as some studies 
used data from across CCG areas (e.g., Delgadillo et al, 2016a), which may have overlapped 
with data contained within other individual IAPT service studies. 
A consistent study limitation concerned the lack of any indices of treatment fidelity, 
integrity or competency (i.e., the studies cannot be sure that what was said to be delivered, was 
actually delivered). IAPT strongly emphasises adherence and fidelity to NICE guidance, 
however, without evidenced fidelity to the particular delivered intervention, this can appear 
meaningless. This may be the mechanism driving the evidence concerning widespread 
differences between therapists (Green et al., 2014), teams and services (Gyani et al., 2013) that 
exists. A lack of fidelity has also implications for internal and external validity, statistical power 
and ethical considerations (Moncher & Prinz, 1991). For example, without treatment adherence 
and fidelity measures it is difficult to truly ascertain that any symptomatic changes following 
treatment is due to that particular treatment. Furthermore, any deterioration in a patients’ 
progress within therapy where fidelity to the model has been less than adequate (or not recorded) 
could lead to arguments that non-adherence of protocols can lead to ‘harm’. Treatment 
adherence, fidelity and integrity can be assessed in various ways, such as through the auditing of 
the use of treatment protocols, matching in-session change methods to the appropriate stage of 
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the treatment protocol, within live supervision, and through the reports provided by patients. 
Evidence has shown a differing uptake of the use of fidelity measures, with one study indicating 
an increase in treatment fidelity reporting within research outputs (Moncher & Prinz, 1991) 
whilst another study did not find this trend (Borrelli, Sepinwall, Ernst, Bellg, & Czajkowski et 
al., 2005). 
There was evidence of high study heterogeneity which is interesting given the aim of 
IAPT being to introduce homogeneity of service delivery. Therefore, whilst there were high 
levels of heterogeneity in the primary meta-analysis, some of this could be accounted for by 
study features, such as those using a completers-type methodology were more likely to be similar 
to each other than those studies using ITT methods. The lack of follow-up studies means that 
relatively little is known regarding the durability of the effects of IAPT.   
 As previously reported, from the available data from the last 6 years (since 2012/2013), 
approximately 4.9 million patients started treatment with just over 2.6 million patients being 
recorded as having completed treatment (i.e., receiving 2 or more sessions within the service). 
From the present systematic review, we have found that a total of just under 1 million patients’ 
data has been included from 60 studies, which indicates that there are substantially more patients 
entering the IAPT programme (even just within the last 6 years of available data), than are being 
reported within published studies from the last 10-years. This is a major mismatch between 
delivery and evaluation. This limits the potential for learning from the IAPT programme and 
potentially improving systems and outcomes. It also highlights just how little research is being 
completed and published in relation to the large amounts of available evidence. 
4.3 Future work and clinical implications 
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 Whilst IAPT continues to expand and evolve, the present review has highlighted 
implications for practitioners working with IAPT services, and also wider service implications. 
Taking into account the small number of studies looking at group interventions, the review 
indicated that group interventions have a similar effectiveness in regard to outcome measure 
compared to individual interventions. This therefore suggests that services could look into 
implementing group interventions more often. This may increase the efficiency of services at no 
loss of effectiveness. Group interventions still require highly skilled delivery and close 
supervision. In the review, group interventions were utilised for individuals with several different 
presenting problems and occurred in both mental health and long-term physical health 
populations – for example, in those experiencing common mental health difficulties, long-term 
conditions (e.g., diabetes) and more enduring conditions (e.g., PTSD) as well as within both low 
and high intensity therapies. This again is encouraging and suggests that group interventions can 
be effective with a range of presenting conditions and at different steps of the IAPT model.  
One of the IAPT programmes’ unique features is that it produces transparent monitoring 
of outcome measures on a large, national scale. As seen within this review, the minimum dataset 
of outcome measures within IAPT includes a measure of depression, anxiety and functional 
disability. Whilst other disorder-specific measures can be used, this review highlighted that 
practitioners are seldom using these to monitor outcome changes. This brings into question 
whether change is being captured accurately. There are no reports of idiographic outcomes in 
IAPT patients and this would supplement nomothetic outcome analysis well. Supplementing the 
minimum dataset with other disorder-specific measures by practitioners would further expand 
the understanding of the IAPT programmes’ impact. Alongside this is the issue of reliable 
competency assessment of interventions at step 2 and step 3 and whether the treatment protocols 
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are being adhered to. Whilst IAPT practitioners have competency assessments integrated into 
their training and post qualification clinical supervision (and they form part of BABCP 
accreditation for CBT therapists), the measures are not reported in the outcome evidence base.  
Future research would therefore benefit from integrating such assessments into their methods. 
In addition to the practitioner and service implications, the current review has also shed 
light onto areas of potential useful future research. The following are indicated (a) studies 
analyzing outcomes on other disorder-specific measures; (b) studies describing the interventions 
in greater detail; (c) consistent use of measures of treatment fidelity and competency; (d) studies 
investigating moderators and mediators of depression and anxiety outcomes; (e) studies 
collecting longer-term follow-up outcomes data; (f) more consistent reporting of drop-out rates, 
and (g) studies modelling and exploring variability between therapists/services/regions and using 
site as a moderator in any future meta-analysis. Any future IAPT outcome paper should as matter 
of course report whether they are taking an IIT versus completer approach, the percentage of 
patients treated at each step, the stepping up rate, the dropout rate, pre and post-treatment means 
(SDs) and effect sizes on the IAPT MDS measures as well the disorder-specific outcome 
measures. In terms of the policy implications, the following are of note; (a) the commissioning of 
routine follow-up data collection, (b) identifying numbers of patients that are re-referred for 
IAPT treatment; (c) open access to routinely collected patient-level IAPT datasets, to enable 
research to keep pace with the often rapidly shifting IAPT policy context. Cross and Hickie 
(2017) have argued that stepped-care models fail to deal with the high levels of comorbidity 
and/or complexity seen in routine services, suggesting that that technically integrated 
transdiagnostic models are more fit for purpose in matching presentation to timely delivery of the 
right intensity and dose of intervention to ensure rapid access. The main clinical implications of 
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the research are; (a) the expansion of choice that has occurred at high intensity (e.g. provision of 
interpersonal psychotherapy, dynamic interpersonal psychotherapy, counselling for depression 
and couple work for depression) has not been mirrored at low intensity and needs to take place 
(e.g. Meadows & Kellett, 2017); (b) there is increasing evidence to support stratified models of 
treatment-matching for more complex cases; (c) solely reporting recovery rates are a limited 
index of the effectiveness of any therapist and/or service and (d) combining the PHQ-9, GAD-7 
and WSAS numbers needed to treat (NNT) results suggests that 2.54 patients need to be seen for 
one patient to gain benefit from an IAPT intervention.  The clinical significance of the results 
overall is that original aim of the IAPT programme was to increase access to evidence-based 
talking treatments and large numbers are being treated annually, with evidence that recovery 
rates are slowly increasing and achieving the 50% target (IAPT, 2019).  This however leaves 
open the possibility of a creating a ‘forgotten-fifty’ of referrals that do not experience any benefit 
and also the so far unrecorded rates of patients that seek further IAPT interventions, thus creating 
a ‘revolving door’ scenario (Cotton, 2019). There is evidence to suggest that patient complexity 
exerts a negative influence on outcomes, particularly when depression is inappropriately treated 
at step 2 initially in IAPT services (Delgadillo, Huey, Bennett, & McMillan, 2017). 
Another area of inquiry could be to continue exploring how IAPT can become more 
effective for people with comorbid long-term conditions and medically unexplained symptoms. 
Within this present review, the extent to which these more physical health conditions are being 
researched, which at the current time is quite limited. In terms of disorder specific outcome 
measures, then more research needs to be produced of effect sizes for IAPT interventions on 
measures well attuned to the presenting problem. There is a clear need for studies to describe the 
interventions used at each step in more detail, to expand the use of measures of fidelity and 
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competency and also to gather short and long-term follow-up outcomes. Within the studies 
quantified using meta-analytic methods (n=29), there were only four studies that included a 
follow-up period, which ranged in length from 4 weeks (Meadows & Kellett, 2017) to an 
average of 42 weeks (Clark et al., 2009). Some recent research has been investigating the use of 
‘top-up’ sessions following IAPT treatment for those individuals who do relapse which has 
shown positive results (Lucock et al., 2018). More studies need to understand what moderates 
and mediates depression and anxiety outcomes at both step 2 and step 3 of IAPT services. More 
research needs to explore why some individuals drop out of or do not benefit from IAPT 
intervention, including areas of harm or deterioration following IAPT intervention. Using mixed 
methods to investigate this particular field of research would open up further areas of exploration 
to continue to understand the impact of the IAPT programme. More studies need to be conducted 
that explore what creates the variability between IAPT therapists, teams and services, rather than 
just recording that variability exists.     
A growing area of research has further explored therapist effects, i.e., the degree to which 
patients treated by different therapists have similar treatment outcomes. There has been variation 
between studies reporting therapist effects, and a recent systematic review indicated a therapist 
effects range of 0.2-29% from different study designs (the majority being practice-based) and 
further supported the notion that it matters most who the therapist is to those who enter treatment 
with higher baseline symptom severity (Johns, Barkham, Kellett & Saxon, 2019). Despite the 
positive and significant results arising from the meta-analysis, there was a lack of longer-term 
follow-up from the majority of the studies. Within the studies quantified using meta-analytic 
methods (n=47), there were only four studies that included a follow-up period, which ranged in 
length from 4 weeks (Meadows & Kellett, 2017) to an average of 42 weeks (Clark et al., 2009). 
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It is important to understand whether the positive and significant outcomes following IAPT 
treatment is maintained long-term, for how long and also for whom. It is expected that relapse 
will occur in some of those clients who made positive progress as has been shown in the 
literature (Ali et al., 2017). Some recent research has been investigating the use of ‘top-up’ 
sessions following IAPT treatment for those individuals who do relapse which has shown 
positive results (Lucock et al., 2018). Other areas of growing research have also been looking 
into those individuals more at risk of both dropping out and of experiencing relapse, with certain 
clinical, demographic and therapist factors contributing to these (Marshall et al., 2016; Ali et al., 
2017). Therefore, if more was known about those who may be at a higher risk of relapse, which 
may be further evidenced by following-up clients going through the IAPT treatment once it has 
finished, there may be potential for working with those individuals to support them in their 
recovery and help to prevent some individuals from relapsing altogether. 
4.4 Conclusion 
  The IAPT programme is an example of public healthcare transformation informed by 
scientific evidence (Clarke, Thomas & James, 2013). A huge amount of investment has occurred 
to enable and then maintain the IAPT programme and it has transformed the landscape of 
psychological services for people with anxiety and depression in the United Kingdom (Firth et 
al., 2019). It has served as a model for other national implementation programmes (e.g., 
Australia, Germany and Canada). It will be interesting to learn reciprocally from these 
programmes (and conduct cross-national meta-analyses) to continue to enhance and improve the 
services for those in receipt of IAPT care. From the results of the present meta-analysis, further 
expansion of the IAPT programme is warranted in the area of physical health, and this has begun 
already albeit it is in the early stage. Further, the results indicate that group interventions, at 
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different steps of the service, appear to show similar effectiveness compared to individual 
interventions. Whilst this should be interpreted with some caution due to smaller study numbers 
in the group sub-group analysis, this is a promising finding which could have encouraging 
implications at a client and service level. The transparency of outcome measurement and the 
sheer scale of data completion is quite unique and thus the learning potential that programmes 
such as IAPT afford are huge (Clark et al., 2018). Regular meta-analyses should supplement the 
reporting of national recovery rates each year. The IAPT programme is yet to achieve its 
scientific potential in offering a unique infrastructure from which further evidence-based practice 
can be developed, at both the national and international level. 
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Appendices 
1: Stepped care model from NICE CG123 
Figure 1: Stepped-care model: a combined summary for common mental health 
disorders 
Focus of the intervention Nature of the intervention 
Step 3: Persistent subthreshold depressive 
symptoms or mild to moderate depression that 
has not responded to a low-intensity 
intervention; initial presentation of moderate or 
severe depression; GAD with marked functional 
impairment or that has not responded to a low-
intensity intervention; moderate to severe panic 
disorder; OCD with moderate or severe 
functional impairment; PTSD. 
Depression: CBT, IPT, behavioural 
activation, behavioural couples therapy, 
counselling*, short-term psychodynamic 
psychotherapy*, antidepressants, combined 
interventions, collaborative care**, self-help 
groups. 
GAD: CBT, applied relaxation, drug 
treatment, combined interventions, self-help 
groups. 
Panic disorder: CBT, antidepressants, self-
help groups. 
OCD: CBT (including ERP), 
antidepressants, combined interventions and 
case management, self-help groups. 
PTSD: Trauma-focused CBT, EMDR, drug 
treatment. 
All disorders: Support groups, befriending, 
rehabilitation programmes, educational and 
employment support services; referral for 
further assessment and interventions. 
Step 2: Persistent subthreshold depressive 
symptoms or mild to moderate depression; 
GAD; mild to moderate panic disorder; mild to 
Depression: Individual facilitated self-help, 
computerised CBT, structured physical 
activity, group-based peer support (self-
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moderate OCD; PTSD (including people with 
mild to moderate PTSD). 
help) programmes**, non-directive 
counselling delivered at home†, 
antidepressants, self-help groups. 
GAD and panic disorder: Individual non-
facilitated and facilitated self-help, 
psychoeducational groups, self-help groups. 
OCD: Individual or group CBT (including 
ERP), self-help groups. 
PTSD: Trauma-focused CBT or EMDR. 
All disorders: Support groups, educational 
and employment support services; referral 
for further assessment and interventions. 
Step 1: All disorders – known and suspected 
presentations of common mental health 
disorders. 
All disorders: Identification, assessment, 
psychoeducation, active monitoring; referral 
for further assessment and interventions. 
* Discuss with the person the uncertainty of the effectiveness of counselling and psychodynamic 
psychotherapy in treating depression. 
** For people with depression and a chronic physical health problem. 
† For women during pregnancy or the postnatal period. 
CBT, cognitive behavioural therapy; ERP, exposure and response prevention; EMDR, eye 
movement desensitisation and reprocessing; GAD, generalised anxiety disorder; OCD, obsessive 
compulsive disorder; IPT, interpersonal therapy; PTSD, post-traumatic stress disorder. 
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Reasons for exclusion n of studies excluded 
Age of client group 94 
Book 181 
Book review 12 
Comment/reply to comment 27 
Commentary/Discussion/Position paper 29 






Mix of IAPT and non-IAPT data 0 
Not pre-post design 12 
Not IAPT 807 
Not IAPT UK 31 
Other 'IAPT' research field 15 
Protocol 63 
Qualitative study 102 
RCT/experiemental design 117 
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Review 168 
Republished article 1 





Reasons for exclusion n of studies excluded 
Age of client group 0 
Book 0 
Book review 0 
Comment/reply to comment 1 
Commentary/Discussion/Position paper 8 






Mix of IAPT and non-IAPT data 4 
Not pre-post design 35 
Not IAPT 145 
Not IAPT UK 14 
Other 'IAPT' research field 1 
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Protocol 1 
Qualitative study 0 
RCT/experiemental design 5 
Review 1 
Republished article 0 
More comprehensive dataset 1 
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3: CASP quality review table 
Table A1: Overview of CASP quality ratings 
 CASP questions             
Paper Q1 Q2 Q3 Q4 Q5a Q5b Q6a Q6b Q71 Q82 Q9 Q10 Q11 Q12 
Adamson et al (2015) Y Y Y Y Y Y N N   Y C/T C/T Y 
Ali et al (2014) Y Y Y Y Y N N N   Y Y Y Y 
Ali et al (2017) Y Y Y Y Y Y Y Y   Y Y Y Y 
Baucom et al (2018) Y Y Y Y Y Y N N   Y C/T Y Y 
Binnie & Boden (2016) Y Y Y Y Y Y N N   Y Y Y Y 
Branson et al (2015) Y Y Y Y C/T N N N   Y C/T C/T C/T 
Branson et al (2018) Y Y Y Y C/T C/T N N   Y C/T C/T C/T 
Buckman et al (2018) Y Y Y Y Y Y N N   Y C/T Y Y 
Burns et al (2016) Y Y Y Y Y N N N   Y Y Y Y 
Chan et al (2014) Y C/T N N C/T Y N N   C/T Y Y C/T 
Cheston et al (2016) Y C/T Y N N N N N   N N C/T N 
Clark et al (2009) Y Y Y Y Y N Y Y   Y Y Y Y 
Clark et al (2018) Y Y C/T Y C/T Y N N   Y C/T C/T Y 
Clarkson et al (2016) Y Y Y Y Y Y N N   Y C/T Y Y 
Delgadillo et al (2014a) Y Y Y Y C/T Y N N   Y Y Y Y 
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Delgadillo et al (2014b) Y Y Y Y Y Y N N   Y Y Y Y 
Delgadillo et al (2016a) Y Y Y C/T C/T Y N N   Y Y Y Y 
Delgadillo et al (2016b) Y Y N Y Y Y N N   Y Y C/T Y 
Delgadillo et al (2016c) Y Y Y Y Y Y N N   Y Y Y Y 
Delgadillo et al (2017a) Y Y Y Y Y Y N N   Y Y Y Y 
Delgadillo et al (2017b) Y Y Y Y Y Y N N   Y Y Y Y 
Delgadillo et al (2017c) Y Y Y Y Y Y N N   Y Y Y Y 
Elison et al (2017) Y Y N C/T Y Y N N   Y Y Y Y 
Firth et al (2015) Y Y Y Y Y Y N N   Y Y Y Y 
Giebel et al (2014) Y Y Y Y Y N N N   Y C/T Y Y 
Goddard et al (2015) Y Y Y Y Y Y N N   Y Y Y Y 
Green et al (2014) Y Y Y Y C/T Y N N   Y Y Y C/T 
Griffiths et al (2014) Y Y Y Y N N N N   C/T Y C/T Y 
Gyani et al (2013) Y Y C/T Y Y Y N N   Y Y Y Y 
Hammond et al (2012) Y Y Y Y Y Y N N   Y Y C/T Y 
Highfield et al (2016) Y C/T N Y N N N N   N C/T C/T N 
Jolley et al (2015) Y C/T Y Y Y N N N   Y C/T C/T C/T 
Kellett et al (2016) Y Y Y Y Y Y N N   Y Y C/T Y 
Kellett et al (2017) Y Y Y Y Y Y N N   Y Y Y Y 
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Kenwright et al (2017) Y Y Y C/T C/T C/T C/T Y   Y Y Y Y 
Kuhn (2011) Y N Y Y N N N N   N N C/T C/T 
Lucock et al (2018) Y C/T Y Y C/T C/T N N   C/T C/T Y Y 
Luik et al (2017) Y Y Y Y C/T N N N   C/T Y C/T Y 
Matthew Prina et al (2014) Y Y Y Y Y Y N N   Y Y C/T Y 
McDevitt-Petrovic et al (2018) Y Y Y Y N N N N   N C/T C/T Y 
Meadows et al (2017) Y Y Y Y Y C/T Y N   Y Y Y Y 
Methley et al (2016) Y Y Y Y N N N N   N C/T C/T C/T 
Mofrad et al (2014) Y C/T Y C/T N N N N   N N C/T C/T 
Morrison et al (2014) Y C/T Y Y Y N N N   Y Y Y C/T 
Murray (2017) Y C/T Y Y N N N N   C/T C/T C/T C/T 
Pack et al (2014) Y Y Y Y C/T N N C/T   C/T Y Y C/T 
Pereira et al (2016) Y C/T Y Y Y Y N N   Y Y C/T C/T 
Pettit et al (2017) Y Y C/T Y C/T N N N   Y Y Y Y 
Poots et al (2014) Y Y C/T C/T C/T N C/T C/T   N C/T C/T C/T 
Pybis et al (2017) Y Y Y Y Y Y N N   Y Y C/T Y 
Radhakrishnan et al (2013) Y Y Y Y Y Y N N   Y Y Y Y 
Richards et al (2011) Y Y Y Y Y Y N N   Y Y Y C/T 
Rimes et al (2018) Y Y Y Y Y Y N N   Y Y Y C/T 
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Saunders et al (2016) Y Y Y Y Y Y N N   Y Y C/T Y 
Saxon et al (2017) Y Y Y Y Y Y N N   Y Y Y Y 
Scott (2018) Y C/T C/T Y N N N N   N C/T N C/T 
Vaillancourt et al (2015) Y Y Y Y C/T N N N   Y C/T Y Y 
Wright et al (2015) Y Y Y Y C/T C/T N N   C/T Y C/T Y 
Wroe et al (2015) Y Y Y Y C/T N N N   C/T Y Y Y 
Young et al (2017) 
Y Y Y Y Y N N N   C/T C/T C/T Y 
1: Please see summary table (Table 3) for overview of each article’s reported findings. 
2: Non-categorical score. 
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4:  
Figure 2: Forest plot, PHQ-9 independent samples effect sizes and pooled effect size, Table 
format 
                      Study    N1    N2    d    ES    SV 
1        Adamson et al 2015   314   313 0.85 0.849 0.007 
2            Ali et al 2014   688   688 0.96 0.959 0.003 
3         Baucom et al 2018    32    31 2.23 2.202 0.102 
4          Burns et al 2016   207   207 0.88 0.878 0.011 
5          Burns et al 2016   211   211 0.95 0.948 0.011 
6           Chan et al 2014    50    50 0.77 0.764 0.043 
7          Clark et al 2009   111   110 1.06 1.056 0.021 
8       Clarkson et al 2016   253   252 0.62 0.619 0.008 
9    Delgadillo et al 2014   1446  1445 0.81 0.810 0.001 
10   Delgadillo et al 2016   2226  2225 0.59 0.590 0.001 
11   Delgadillo et al 2017    254   253 0.22 0.220 0.008 
12   Delgadillo et al 2017     69    68 0.26 0.259 0.029 
13   Delgadillo et al 2017     56    55 0.05 0.050 0.036 
14   Delgadillo et al 2017     67    67 0.50 0.497 0.031 
15   Delgadillo et al 2017   1158  1158 0.10 0.100 0.002 
16         Firth et al 2015  3056  3055 0.82 0.820 0.001 
17        Giebel et al 2014   183   183 0.63 0.629 0.011 
18         Green et al 2014   561   561 0.52 0.520 0.004 
19     Highfield et al 2016    14    14 1.86 1.806 0.201 
20       Kellett et al 2016   422   422 0.94 0.939 0.005 
21       Kellett et al 2016    87    87 0.74 0.737 0.025 
22       Kellett et al 2017    13    13 0.73 0.707 0.163 
23     Kenwright et al 2017    24    24 0.98 0.964 0.093 
24     Kenwright et al 2017    40    39 1.56 1.545 0.066 
25                Kuhn 2011    26    26 1.28 1.261 0.092 
26        Lucock et al 2018     6     5 0.50 0.457 0.376 
27          Luik et al 2017    36    35 1.33 1.315 0.069 
28       Meadows et al 2017     5     5 1.02 0.921 0.442 
29      Morrison et al 2014     6     6 1.06 0.978 0.373 
30          Pack et al 2014    25    25 0.79 0.778 0.086 
31         Pybis et al 2017 11798 11797 0.94 0.940 0.000 
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32         Pybis et al 2017  4824  4824 0.95 0.950 0.000 
33 Radhakrishnan et al 2013  4232  4232 0.72 0.720 0.001 
34      Richards et al 2011  2092  2091 1.07 1.070 0.001 
35        Wright et al 2015    12    12 0.44 0.425 0.170 
36         Young et al 2017    49    49 1.02 1.012 0.046 
37         Young et al 2017   183   183 1.15 1.148 0.013 
 
Figure 4: Forest plot, GAD-7 independent samples effect sizes and pooled effect size, Table 
format 
          Study   N1   N2    d    ES    SV 
1        Adamson et al 2015  314  313 0.96 0.959 0.007 
2            Ali et al 2014  688  688 1.00 0.999 0.003 
3         Baucom et al 2018   32   31 1.80 1.778 0.089 
4          Burns et al 2016  256  256 1.04 1.038 0.009 
5          Burns et al 2016  245  245 1.05 1.048 0.009 
6           Chan et al 2014   50   50 0.93 0.923 0.044 
7          Clark et al 2009  111  110 1.26 1.256 0.022 
8       Clarkson et al 2016  253  252 0.63 0.629 0.008 
9    Delgadillo et al 2014  1446 1445 0.90 0.900 0.002 
10   Delgadillo et al 2016  2226 2225 0.70 0.700 0.001 
11   Delgadillo et al 2017   254  253 0.27 0.270 0.008 
12   Delgadillo et al 2017   69   68 0.33 0.328 0.030 
13   Delgadillo et al 2017   56   55 0.13 0.129 0.036 
14   Delgadillo et al 2017   67   67 0.58 0.577 0.031 
15   Delgadillo et al 2017  1158 1158 0.11 0.110 0.002 
16         Firth et al 2015 3056 3055 0.90 0.900 0.001 
17        Giebel et al 2014  183  183 0.63 0.629 0.011 
18         Green et al 2014  561  561 0.55 0.550 0.004 
19     Highfield et al 2016   14   14 1.88 1.825 0.202 
20       Kellett et al 2016  422  422 0.93 0.929 0.005 
21       Kellett et al 2016   87   87 0.86 0.856 0.025 
22       Kellett et al 2017   13   13 0.49 0.475 0.158 
23     Kenwright et al 2017   24   24 1.32 1.298 0.101 
24     Kenwright et al 2017   40   39 1.39 1.376 0.063 
25                Kuhn 2011   26   26 1.15 1.133 0.089 
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26        Lucock et al 2018    6    5 0.09 0.082 0.367 
27          Luik et al 2017   36   35 0.79 0.781 0.061 
28       Meadows et al 2017    5    5 1.33 1.201 0.472 
29          Pack et al 2014   25   25 0.82 0.807 0.087 
30 Radhakrishnan et al 2013 4232 4232 0.82 0.820 0.001 
31      Richards et al 2011 2092 2091 1.04 1.040 0.001 
32        Wright et al 2015   12   12 0.63 0.608 0.174 
33         Young et al 2017   49   49 0.86 0.853 0.045 
34         Young et al 2017  183  183 1.10 1.098 0.013 
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Table S2: Subgroup analysis of pre-post treatment effects in the typical study sample (n=8 atypical studies excluded) 
 
Outcome Variable Subgroup k Effect 
size 




PHQ-9  Methodology ITT 37 0.77 0.65 to 0.89 99% 5636.35*** <.001** 
 COM 20 1.04 0.96 to 1.12 99% 3121.97***  
 Study bias Low 40 0.81 0.70 to 0.93 99% 5518.52*** .061 
  Medium 14 0.94 0.83 to 1.06 99% 4029.45***  
  High  3 1.26 0.84 to 1.68 83% 11.95**  
 Primary condition Mental health 45 0.93 0.86 to 1.01 99% 8985.62*** .002** 
 Physical health 10 0.43 0.13 to 0.74 94% 170.82***  
 Step of care Step 2 only 15 0.80 0.68 to 0.93 97% 686.96*** .013* 
  Step 3 only 6 1.05 0.90 to 1.20 94% 83.76***  
 Format Individual  32 0.75 0.62 to 0.89 99% 5133.20*** .454 
  Group 6 0.88 0.59 to 1.16 92% 69.92***  
GAD-7 Methodology ITT 35 0.79 0.66 to 0.91 99% 5425.53*** <.001** 
 COM 17 1.07 0.99 to 1.15 99% 3964.94***  
 Study bias  
 
Low 37 0.82 0.71 to 0.94 99% 3600.73*** <.001** 
 Medium 13 0.98 0.84 to 1.13 99% 5215.82***  
  High  2 1.51 1.49 to 1.53 0% 0  
 Primary condition Mental health 40 0.96 0.88 to 1.04 99% 10732.73*** .006** 
 Physical health 10 0.50 0.19 to 0.82 94% 175.50***  
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 Step of care Step 2 only 14 0.88 0.74 to 1.03 98% 776.13*** .366 
  Step 3 only 3 1.15 0.58 to 1.73 87% 16.21*  
 Format 
 
Individual 27 0.75 0.58 to 0.91 99% 4746.63*** .283 
 Group 6 0.91 0.66 to 1.16 93% 73.78**  
WSAS1 Methodology ITT 19 0.56 0.49 to 0.63 98% 1224.64*** .363 
  COM 2 0.46 0.27 to 0.66 0% 0.71  
 Study bias Low 17 0.57 0.49 to 0.64 97% 772.84** .438 
  Medium 4 0.49 0.33 to 0.66 99% 810.27***  
 Step of care Step 2 only 7 0.52 0.43 to 0.61 98% 432.12*** - 
  Step 3 only 1 0.50 - - -  
 Format Individual 9 0.51 0.42 to 0.59 99% 908.50 .568 
  Group 2 0.48 0.45 to 0.51 0% 0.87  
*significant at p < .05 threshold; **significant at  p < .01 threshold, ***significant at  p < .0001 threshold, between subgroup differences significant at 
Bonferroni adjusted p<.01 threshold for multiple testing; *1 Moderator analysis for ‘primary condition’ was not undertaken for the WSAS outcome measure as 
all studies included were deemed to be investigating mental health with none focusing purely on physical health. Abbreviations: k: number of comparisons per 
subgroup, CI: confidence interval, PHQ-9: Patient Health Questionnaire-9, GAD-7: Generalized Anxiety Disorder scale-7; WSAS; Work and social adjustment 
scale; ITT: Intention to treat; COM; completer. .
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Note: *significant at p < .05 threshold; **significant at  p < .01 threshold, ***significant at  p < .0001 threshold, significant at Bonferroni adjusted p<.01 
threshold for multiple testing; Abbreviations: k: number of comparisons, CI: confidence interval; SE: standard error; M: mean; PHQ-9: Patient Health 
Questionnaire-9, GAD-7: Generalized Anxiety Disorder scale-7; WSAS; Work and social adjustment scale. 
Outcome Variable Range and mean k 
B-
coefficient 
95% CI SE p 
PHQ-9  Gender (% female) (0 – 100%; M=59.5) 44 -0.01 -0.01 to 0.00 0.00 <.001*** 
Mean age (31 – 49 years; M=39.8) 40 -0.01 -0.02 to 0.01 0.01 .483 
 Mean intake score (7.9 – 18.8; M=15.0) 51 0.03 0.01 to 0.05 0.01 .012* 
 Mean number of sessions (3 – 16 sessions; M=6.7) 35 0.04 0.02 to 0.07 0.01 <.001*** 
GAD-7 Gender (% female) (0 – 100%; M=59.1) 41 -0.00 -0.00 to 0.00 0.00 .001** 
Mean age (31 – 49 years; M=39.7) 38 -0.01 -0.02 to 0.01 0.01 .481 
 Mean intake score (3.7 – 18.3; M=13.5) 45 0.07 0.04 to 0.09 0.01 <.001*** 
 Mean number of sessions (3 – 16 sessions: M=6.6) 31 0.04 0.01 to 0.07 0.01 .002** 
WSAS Gender (% female) (0 – 100%; M=54.9) 19 -0.00 -0.00 to 0.00 0.00 .041* 
 Mean age (31 – 49 years; M=39.3) 17 0.00 -0.02 to 0.03 0.01 .738 
 Mean intake score (14.8 – 24.5; M=19.3) 20 0.02 -0.01 to 0.05 0.01 .127 
 Mean number of sessions (4 - 16 sessions; M=6.7) 16 0.03 -0.02 to 0.07 0.02 .201 



















Part 2: Research Report 
The effectiveness of brief cognitive analytic therapy for clients with depression and anxiety: a 
pilot study. 
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Abstract 
Objectives: To investigate the effectiveness of brief cognitive analytic therapy (CAT) for 
anxiety and depression via a comparison with matched cases receiving cognitive behavioural 
therapy (CBT). 
Methods: A pilot treatment comparison analysis of routinely collected sessional outcomes 
for CAT and CBT. The setting for the study was an Improving Access to Psychological 
Therapies (IAPT) service. The measures used were the PHQ-9, GAD-7 and WSAS.  
Propensity score matching (PSM) was used to create equivalent CAT and CBT samples that 
received up to 8-sessions of treatment. Longitudinal multilevel modelling (LMLM) was then 
used to investigate rates of symptomatic change between the two therapies. 
Results: The primary longitudinal ML model was not significant, indicating few differences 
between the outcomes achieved by the two therapies (i.e. outcomes did not change as a 
function of the interaction between Time (i.e., sessional outcomes over time) and Sample 
(i.e., CAT vs CBT). This suggests that the trajectories of symptomatic and severity-level 
changes that occur over time were similar in both treatment models. Regression analyses also 
indicated no significant differences in the rate of change when comparing CAT and CBT. 
Effect size calculations indicate small between-group post-treatment effects. 
Conclusions: The results are discussed with reference to the equivalence paradox for 
routinely delivered psychological therapies. Limitations of the study are labelled, and the 
design of future studies discussed. Whilst CAT shows some promise as a potential IAPT high 
intensity therapy, future research is clearly indicated. 
 
Practitioner points:  
• Practitioners under appropriate supervision could consider using a brief 8-session 
CAT when treating patients with anxiety and depression.   
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• The brief 8-session version of the model developed for use in Primary Care appears to 
hold some organisational promise.  
• Practitioners need to ensure that brief CAT interventions still retain the theoretical 
integrity and so adhere to the reformulation, recognition and revision structure of the 
model.   
 
Keywords: Improving Access to Psychological Therapies, IAPT, cognitive analytic therapy, 
CAT, cognitive behavioural therapy, CBT, practice-based, outcome measures, depression, 
anxiety, functioning. 
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1. Introduction 
Mental health care features on the UK Government’s agenda consistently (Layard, 
2014). For example, in 2012, the Health and Social Care Act set out to achieve a ‘parity of 
esteem’ between mental and physical health services (Department of Health, 2012). The 
system for delivering evidence-based psychological therapies in the UK is informed by the 
National Institute for Health and Care Excellence (NICE) guidelines for the treatment of 
anxiety, depression, obsessive compulsive disorder (OCD) and post-traumatic stress disorder 
(PTSD). NICE guidance is informed by research and is hierarchical in nature (i.e., the most 
evidence generated by robust randomised controlled trials (RCTs) are given largest 
weightings, followed by less robust research evidence, such as cohort studies). Cognitive 
behavioural therapy (CBT) features in the NICE guidelines for the common mental health 
problems (i.e. anxiety disorders and depression) due to its robust evidence base in 
comparison to other psychotherapies. In routine services there has been a shift to delivery of 
CBT-informed therapies being manualised in order to create greater therapist adherence to 
the evidence base and to ensure evidence-based practice. Through continued rigorous 
research efforts, CBT as a therapeutic model has developed an extensive evidence base and 
became the initial cornerstone for the UK’s national primary care mental health programme. 
1.1 Improving Access to Psychological Therapies 
The Improving Access to Psychological Therapies (IAPT) programme was developed 
in 2008, and its remit was to increase the access to evidenced based psychological therapies 
for people experiencing common mental health problems. It has continued to develop and 
expand since its first inception, and now is inclusive of all ages and covers a large range of 
conditions such as depression, generalised anxiety disorder, post-traumatic stress disorder, 
social anxiety disorder, obsessive-compulsive disorder, panic disorder, specific phobias, and 
other problems. It also covers the treatment of psychological distress associated with log-term 
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physical health conditions (Clark, Canvin, Green, Layard, Pilling & Janecka, 2018). IAPT is 
based on a stepped-care model (Figure 1) that delivers low and high intensity psychological 
interventions. As a first-line treatment to those accessing the service, briefer and less 
intensive therapies can be offered which typically range from 6-8 sessions and formats for the 
delivery of low-intensity interventions can include telephone, group, 1:1 or computerised 
treatment (The National Collaborating Centre for Mental Health, 2018). The stepped care 
aspect of the model means individuals can be ‘stepped up’ if they do not respond to low-
intensity treatments or their risk changes, to more high-intensity therapies which are typically 
lengthier (up to 20 sessions).  
There has been a more recent move in IAPT to increase the plurality of intervention at 
step 3. However, a recent study reported that of 114 services analysed, only one service 
offered the full range of the five NICE-recommended therapies for depression (i.e., CBT, 
IPT, couples therapy, counselling, psychodynamic psychotherapy), whilst 40 services offered 
four of the five recommended therapies (Perfect, Jackson, Pybis & Hill, 2016). The offer of 
differing therapies is based on the evidence that few differences are apparent between 
therapies offered in routine. For example, patient outcomes between CBT and counselling 
treatments have found the two to be generally comparable (e.g., Pybis et al., 2017); briefer 
forms of counselling for depression (2-7 sessions) have a larger impact on recovery rates, 
whilst the benefits of CBT are generally better following longer treatments (above 8 sessions) 
(Pybis et al., 2017). On average, treatment duration is around seven sessions in IAPT services 
(December 2018: Health and Social Care Information Centre, 2019). 
IAPT services across England collect data from standardised patient-reported 
outcome measures on a session-by-session basis, which are used to monitor patients’ 
response to treatment and to inform decisions about treatment planning. Typically, patients 
complete validated measures of depression, anxiety and functional impairment at the start of 
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each treatment session, and this is reviewed with their therapists as part of the therapy 
process. This information is then input into computerised data collection systems that enable 
services to assess their clinical performance. These data are anonymised and made publicly 
available each month and shared via NHS Digital. To put the scale of the outcome monitoring 
into context, the most recent monthly data available (November 2019) indicated that over 
98,000 individuals began therapy within IAPT and the average number of sessions each 
individual will receive is 7 (NHS Digital, 2020). The IAPT evidence base consists of the 
publicly available outcomes, a large pool of evidence-based research studies (Wakefield et 
al., in press) and a small number of RCTs (Richards et al, 2016).  
A standardised set of outcome measures, known as the ‘minimum data set’ (MDS), is 
utilised which matches the most common presenting problems. The MDS includes a measure 
of depression symptomatology (Patient Health Questionnaire (PHQ-9): Kroenke, Spitzer & 
Williams, 2001), a measure of anxiety symptomatology (Generalised anxiety disorder (GAD-
7): Spitzer, Kroenke, Williams, & Lowe, 2006), and a measure of functional disability (Work 
and Adjustment Scale (WSAS): Mundt, Marks, Shear, & Greist, 2002). IAPT uses the 
‘recovery’ indicator to assess the effectiveness of interventions, with ‘reliable recovery’ 
indicating that an individual patient moves below the caseness threshold on all measures at 
the end of treatment (National Collaborating Centre for Mental Health, 2019). A 50% 
recovery rate is set as a target for all IAPT services. This counts the number of patients who 
were above the clinical threshold on depression and/or anxiety at pre-treatment, with 
recovery occurring if a patient subsequently scores below the clinical threshold on depression 
and anxiety at the end of treatment. This 50% figure is drawn from the results of the clinical 
trials that make up the evidence base that forms the NICE guidelines. The latest figures show 
that this recovery rate is being met with the November 2019 figures indicating a 50.6% 
recovery rate (NHS Digital, 2020). ‘Disorder-specific’ measures are also intended to be used 
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when relevant to the individual client and their presenting difficulty (National IAPT 
guidance, 2010), however these appear to be collected less often than may be necessary 
(Wakefield, Kellett, Simmonds-Buckley, Stockton, Bradbury & Delgadillo, in press). 
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Figure 1: The proposed stepped-care model for IAPT services. 
 
1.2 Cognitive analytic therapy 
Cognitive analytic therapy (CAT) was first proposed as a bone fide psychotherapy in 
1985 (Ryle & Kerr, 2002). Anthony Ryle pioneered this therapy during a time when the NHS 
was pressured both for time and finances – making CAT as relevant today in the current NHS 
climate as it was during its inception. CAT is a time-limited, relational, collaborative and 
integrative therapy which draws from both cognitive and analytic theories (Ryle, Kellett, 
Hepple & Calvert 2014). Specifically, it integrates analytic theory relating to object relations 
(Ogden, 1983) with cognitive theory of personal constructs (Kelly, 1956). Self to self, self to 
other, and other to self relationship patterns are summarised as ‘reciprocal roles’ (RRs) and 
are a reflection of the analytic aspect of the theory, with resultant procedural sequences 
reflecting the cognitive element (Ryle & Kellett, 2019). Generally, CAT is offered over 8, 16 
or 24 sessions plus a follow-up period (Ryle & Kerr, 2002) and follows a reformulation, 
recognition, and revision structure (Ryle & Kellett, 2019). 
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CAT has become popular with therapists and has grown and developed notably from 
its first inception over 30-years ago to now be delivered internationally (Ryle et al, 2014). 
CAT is largely used with clients with severe and debilitating difficulties, such as those 
diagnosed with ‘personality disorders’ (Kellett, Bennett, Ryle & Thake, 2013; Clarke, 
Thomas & James, 2013). However, more recently CAT has expanded and research studies 
into the use of CAT with other clinical populations have gained momentum. For example, 
CAT has shown beneficial effects with clients struggling with eating disorders (Treasure et 
al., 1995), morbid jealousy (Kellett & Totterdell, 1995), and has also been utilised in physical 
health settings with clients following acquired brain injuries (Yeates et al, 2008). CAT has 
been criticised for developing an evidence base with complex psychological disorders at the 
expense of the common mental health problems (Hammonds, Simmonds-Buckley & Kellett, 
2020). There is a small evidence base for the effectiveness of CAT with anxiety and 
depression, with the studies being limited by the completion of simple pre and pest designs 
(Calvert & Kellett, 2014). A recent meta-analysis of the CAT evidence base (Kellett et al, 
2020) included 28 studies (k=10 RCTS and k=18 PBE) studies showing significant reductions 
in depression symptoms (ES=1.05, Z=9.17; p<.001). 
In clinical practice, whilst the research element of CAT is somewhat lacking, the 
model is continuing to evolve and increase in its applicability to different situations.  For 
example, a recent dismantling CAT trial investigated a brief 8-session CAT within IAPT for 
clients with depression (randomised to either reformulation letter or no reformulation letter) 
and found significant reductions to depression at both end of treatment and follow-up, with 
associated improvements in levels of functioning (Kellett et al, 2018). Due to the impetus to 
increase the range of therapies offered at step 3 of IAPT services, it is particularly worthwhile 
to investigate CAT in relation to ‘treatment as usual’ (i.e., CBT). This is particularly 
important given that CAT is a time-limited and structured psychotherapy and that could 
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potentially fit in well with the IAPT programme. Other treatments that have a psychodynamic 
orientation origin and a time-limited structure, such as Interpersonal Psychotherapy (IPT), 
have been implemented into the available treatments for patients and thus the current study 
can add to this growing list of potential available treatment options for patients accessing 
IAPT services (e.g., Wright & Abrahams, 2015). The outcomes achieved by the 8-session 
version of the model are particularly ripe for investigation, as the average number of sessions 
in IAPT is seven (NHS Digital, 2020) and therefore the design and evaluation of a therapy to 
fit that evidence is indicated. Therefore, a practice-based evidence pilot study is reported here 
that investigated the effectiveness of brief 8-session CAT in comparison to well-matched 
CBT treatment cases. 
1.3 Aims 
The proposed study aimed to analyse practice-based evidence of CAT and high 
intensity CBT for well-matched patients attending at an IAPT service for common mental 
health difficulties. Growth curve models using sessional outcome measures will be defined 
and compared to investigate the trajectories of change across the two therapies. The study 
also sought also to define the effect sizes achieved in CAT and CBT. We did not expect any 
statistically significant differences between treatments, based on the prevalence of the 
equivalence paradox in routine practice (i.e., bone fide psychotherapies tend to produce 
similar post-treatment outcomes). 
1.4 Hypotheses 
i. CAT and CBT have similar change trajectories over sessional time (primary analysis). 
ii.  Effect sizes will not differ between CAT and CBT. 
iii. The acceptability of CAT (i.e., the dropout rate) will be comparable to CBT. 
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2. Methodology 
2.1 Study design 
 A retrospective, single-site pilot study from a routine IAPT service comparing clinical 
outcomes on pre-existing datasets. In this study, datasets have been recorded within the IAPT 
service via routine clinical practice during step 3 interventions (CAT and CBT). The study 
utilised IAPT sessional outcome data to investigate trajectories of change in this data. As is 
routine in IAPT, clients attending the services therefore completed relevant sessional 
measures that allowed to track change for individuals during therapy. 
2.2 Setting   
The research dataset was drawn from individuals who attended an IAPT service based 
at a site within the South of England. The IAPT service has stepped-care and so offers 
evidence-based treatments with qualified professionals trained to deliver step-3 (high 
intensity) interventions, based on NICE recommendations, for individuals referred with 
common mental health problems. The service was also piloting the use of an 8-session CAT 
intervention. 
2.3.1 8-session CAT model description 
 A description and outline of the 8-session CAT model has been detailed elsewhere 
(White & Hepple, in submission). CAT was designed to be offered in the service where the 
presenting difficulties raised by patients contained ‘complex relational problems, personality 
disorder traits or histories of adverse childhood experience’. The reformulation letter aspect 
of CAT was removed due to implications on therapist time and evidence from the Kellett et al 
(2018) dismantling study showing that narrative reformulations does not improve outcomes. 
The therapy still adhered to the reformulation, recognition and revision structure of the model 
(Ryle & Kellett, 2019), as target problem procedures (TPPs) were identified early in 
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treatment, a sequential diagrammatic reformulation (SDR) was completed by mid-treatment 
and goodbye letters were shared between patients and therapists at the end of treatment. The 
tools of CAT (e.g. the psychotherapy file and TPP rating sheets) were also included. All the 
CAT treatments were supervised by an ACAT accredited CAT psychotherapist and 
supervisor. A brief description of the stages of the 8-session CAT model is outlined: 
 Early sessions (1-3):  The therapist introduces the premises around CAT, particularly 
the relational nature of the therapy. Both therapist and patient collaborate to understand 
relationship patterns from the patients past and collaborate to identify ‘target problems’ (TPs) 
that the patient wants to focus on during the therapy and the TPPs that maintain the target 
problems in the current day and that may disable or interfere with the effectiveness of the 
therapy. The therapist also draws on their experience of the patient in the session (and 
through use of supervision) to start to build the case formulation and includes information 
from the Psychotherapy File. The central aim of the initial phase of treatment is to 
conceptualize how past relationships may be impacting on present relationships, including the 
therapeutic relationship via identification and patient monitoring of TPs and TPPs.   
 Mid-session (4): The introduction of the concept of reciprocal roles is introduced here 
and mapped out visually  by the therapist to the patient in the form of a sequential 
diagrammatic reformulation (SDR), which visually summarises the key reciprocal roles and 
the procedures that link them. In collaboration, the therapist and patient map therefore map 
out the reciprocal roles that summarize self-to-self, self-to-other and other-to-self relating  
that are based in early experiences and also the current day procedures that maintain the 
reciprocal roles. The patient and therapist also use the SDR to enable the patient to recognize 
when reciprocal roles and procedures are being enacted in close relationships, including the 
therapeutic relationship via enactment analysis and also rupture repair efforts.   
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 Later sessions (5-7): This is the phase of CAT which is focused on facilitating change 
in reciprocal roles and associated procedures. Analysis of enactments and also ruptures 
within the therapeutic relationship continue to be part of the change process. Therapists also 
encourages the patient to create ‘exits’ on the SDR to change reciprocal roles and disrupt 
procedures ad these are put into place in the patient’s life outside of therapy. ‘Exits’ in CAT 
are catholic and as long as they are based in the SDR then the therapist is free to work using 
any change method, as long as this is within the patient’s zone of proximal development 
(Ryle & Kellett, 2019).  The goodbye letter is planned at session 7 and these are shared at 
session 8. There is a worksheet to provide patients with advice on what might be helpful to 
reflect on and therefore contains relational prompts. 
Final session (8): The therapist and patient their share goodbye letters in this final 
session, capturing the relational understanding that has been built-up collaboratively during 
the therapy, labelling what are effective exits and how these can be maintained and also 
naming relapse prevention strategies (Ryle & Kellett, 2019). 
2.3.2 CBT model description 
IAPT CBT interventions are highly standardised and delivered following the 
treatment protocols drawn from randomised controlled trials (RCTs) forming the basis of the 
depression and anxiety NICE guidelines (CG 90; CG 113).  CBT treatments are also 
underpinned by the competencies framework for the cognitive or behavioural treatment of 
anxiety and depression (Roth & Pilling, 2008).  IAPT CBT interventions are typically 16-20 
sessions.  There are two treatment protocols for depression, one is cognitive (Beck, Rush, 
Shaw, & Emery, 1979) and one is behavioural (Martell, Addis, & Jacobsen, 2001). The 
protocols for the range of anxiety disorders, OCD, BDD and PTSD are all cognitive-
10 years of IAPT: a meta-analysis              108 
behavioural.  All the protocols share the common ingredients of a disorder-specific 
formulation, within-session change methods, homework and relapse prevention.  
2.4 Sample selection and characteristics 
Ethical approval was sought to access the dataset (South of England: 19/HRA/0025, 
16th May 2018), including comparator CBT treatments (see Appendix 4). The following 
inclusion and exclusion criteria were used: 
Inclusion Criteria 
• Adult patients who accessed high intensity CBT or 8-session CAT in the participating 
IAPT site; 
• CAT was in particular offered to patients with difficulties that are recognised as 
experiencing common mental health problems (i.e., depression and/or anxiety) that reflect 
complex relational problems, personality disorder traits or histories of adverse childhood 
experience; 
• Patients either completed therapy or dropped out of therapy. 
Exclusion Criteria 
• Patients who completed a treatment modality other than CAT or high intensity CBT; 
• Patients that had a CAT treatment that lasted longer than 8-sessions; 
• Patients who did not complete any treatment sessions (i.e., only completed assessment 
session). 
The CONSORT flow diagram in Figure 2 outlines how those who met inclusion into 
the study were filtered into the final datasets that were analysed for this study.
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Figure 2: Sample selection diagram 
South of England dataset  
Assessed for eligibility (n = 2078) 
Potential pool of cases (n = 500) 
CBT (n=424) 
CAT (n=76) 
Excluded (n = 1578) 
Reason: 
Not CBT or CAT treatment (n=1578) 
Excluded (n = 351) 
Reason: 
PSM unmatched (n=351) 
 PSM matched sample (n = 149) 
PSM matched 
CAT cases (n=76) 
PSM matched 
CBT cases (n=73) 
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2.5 Outcome measures: 
Outcome measures were completed at an initial appointment, as well as at each 
treatment session. Measures are collected routinely within all IAPT services and therefore the 
measures are pre-determined (IAPT minimum dataset described below). Details, including 
psychometric evidence, are outlined below: 
Generalised Anxiety Disorder (GAD-7) (Spitzer, Kroenke, Williams, & Lowe, 
2006) - The GAD-7 measures anxiety symptom severity. The 7-items are scored on a Likert 
scale of 0-3 (score range 0-21; higher scores indicating worse symptoms). Psychometric 
properties have reported good validity and reliability using a cut-off ≥8 to identify clinically 
significant anxiety disorders, with sensitivity and specificity values of 89% and 82%, 
respectively (Spitzer et al., 2006). 
Patient Health Questionnaire (PHQ-9) (Kroenke, Spitzer & Williams, 2001) - The 
PHQ-9 measures depression symptom severity. The 9-items are scored on a Likert scale of 0-
3 (score range is 0-27; higher scores indicating worse symptoms). Psychometric properties 
have been reported and research has indicated excellent validity and reliability (Kroenke et 
al., 2001) using a clinical cut-off ≥10, with sensitivity and specificity values of .77 and .94, 
respectively (Wittkampf et al., 2007). 
Work and Social Adjustment Scale (WSAS) (Mundt, Marks, Shear, & Greist, 2002) 
- The WSAS measures the impact of MH on a person’s ability to function in the areas of 
work, home management, social leisure activities, private leisure activities and close 
relationships. The 5-items are scored on a Likert scale of 0-8 (score range is 0-40; higher 
scores indicating worse symptoms). Psychometric properties have shown the WSAS to have 
good internal, temporal reliability and is sensitive to differences in disorder severity and 
responsivity to treatment (Purdie, Kellett, & Bickerstaffe, 2012). 
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2.6 Data preparation 
Data was prepared using the Statistical Package for Social Sciences (SPSS) v.25 The 
data cleaning process entailed several steps. The initial cleaning required identification of 
patients who had accessed only those included treatment modalities (i.e., CAT or CBT 
delivered at step 3). New variables into the data were created, which could identify first and 
last treatment session, and a new ‘Sample’ variable was added to classify which treatment 
each individual patient had accessed for the upcoming analysis. 
Following data cleaning, propensity score matching (PSM) was applied. This is a 
method that enables case-control matching of participants within each treatment based on 
available characteristics. The PSM method is a valid statistical tool that mimics the 
randomisation procedure used in RCTs to match groups as equivalent as possible on 
important factors (Beal & Kupzyk, 2014). Using the CAT group as the reference group, the 
PSM procedure was set-up to match with CBT cases based on age, gender and baseline 
scores (PHQ-9, GAD-7, WSAS). 
2.6.1 Missing Data 
An intention to treat analysis was completed therefore all data from participants who 
commenced therapy was utilised. As the intention was to utilise longitudinal multilevel 
modelling analyses, missing data did not need to be imputed, as this approach is capable of 
modelling growth curves over missing data-points (Singer & Willett, 2003). 
2.7 Statistical Analyses 
2.7.1 Baseline comparisons of sample characteristics 
 Data was analysed using the Statistical Package for Social Science (SPSS) v.25. 
Analysis of the data firstly investigated baseline characteristics of each of the samples prior to 
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the PSM procedure and then following matching of samples. Here, non-parametric tests 
(Mann Whitney-U, Chi-Square) were employed to compare any differences between groups, 
including those who have been included and excluded from the final sample. 
2.7.2 Primary analysis 
The primary analysis consisted of analysing the research dataset (n=149) with the 
final PSM treatment modality samples (CAT n=76; CBT n=73). PSM is a statistical method 
that enables case-control matching in such a way that balances important baseline (pre-
treatment) characteristics, as a way to artificially mimic the balancing of covariates that is 
achieved in randomised controlled trials (Beal & Kupzyk, 2014; Rosenbaum & Rubin, 1983). 
This matching procedure was based on a logistic regression predicting CAT group 
membership, entering all available demographic and pre-treatment clinical measures as 
predictors (age, gender, PHQ-9, GAD-7, WSAS), using a one-to-one nearest neighbours 
approach with a conservative tolerance level (caliper = 0.2) specified a priori, and allowing 
replacement to maximize matching precision. This one-to-one matching process should –in 
theory– result in two balanced treatment samples (CBT; CAT) with identical sample sizes. 
However, obtaining identical sample sizes depends on the extent to which an exact match 
(based on the available baseline characteristics) is found for every single case in the sample. 
In practice, sometimes this procedure yields close but not identical sample sizes in the 
matched samples (Rosenbaum & Rubin, 1983). 
The primary analysis was undertaken using longitudinal multilevel modelling (MLM) 
to investigate any differences in the treatment trajectories using the sessional data from the 
outcome measures (PHQ-9, GAD-7, WSAS). Any patient that had received treatment within 
the IAPT service that lasted more than 8-sessions were analysed in a way to ensure only the 
initial 8-sessions of CAT were evaluated. The CBT comparison group contained treatment 
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contacts of up to sixteen sessions. Therefore, the CBT comparator group contained therapies 
that had been longer than 8-sessions, but the first 8-sessions were used to create the 
comparisons with CAT in the subsequent growth curve modelling. Both and CAT and the 
CBT comparators groups therefore could contain therapies of less than 8-sessions, due to 
patient drop-out. This meant that a direct comparison of the effectiveness of the two therapies 
could be undertaken, with this method also eliminating any potential differences between the 
two treatment groups due to factors regarding treatment length.  Each outcome measure was 
analysed in separate longitudinal MLM models. A two-level model was created which 
included session-by-session outcome measure scores (level 1) nested within cases (level 2). 
The model had both fixed and random effects (random intercepts and random slopes for 
time), with an unstructured covariance structure. The analysis followed conventional 
guidelines for multilevel modelling, which build regression models in a series of steps, 
progressing from unconditional to fully adjusted (conditional) models that are optimised for 
goodness-of-fit (Singer & Willett, 2003). In the first part of the analysis the initial task was to 
develop unconditional models which fit different time trends across the data to find the 
closest fit. The trends used were: linear, quadratic, cubic and log-linear. The model with the 
best goodness-of-fit was determined by the -2*loglikelihood ratio test, and the equation for 
this is as follows: 
X2 Change = (-2*Log Likelihoodold) | (-2Log Likelihoodnew) 
Df Change = Number of parametersold - Number of parametersnew 
(Field, 2009) 
Following this, a conditional growth curve model was built, adding ‘Sample’ (i.e., treatment 
modality group; CAT or CBT) as a predictor to test how outcomes changed between groups 
over time: Time*Sample interaction.  
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Growth curve analyses (or, growth curve modelling: GCM) were used to compare 
patterns of mean-level changes longitudinally. Advantages of using GCM include that it is a 
robust enough method to allow for missing data, unequal sample sizes and differing time 
intervals between data points (e.g., Shek & Ma, 2011). GCM analyses data at both a within-
subjects (level 1) and between-subjects level (level 2). In the current data set, the within-
subjects level included sessional data (level 1) nested within each individual patient (level 2); 
therefore the ‘Sample’ variable was conceptualised as a level-2 (between-subjects) predictor. 
2.7.3 Secondary analyses 
Between-groups effect sizes were calculated for all outcome measures comparing 
post-treatment means between the CAT and CBT treatments. This was completed within the 
main PSM sample. Effect sizes are reported using Cohen’s d (Cohen, 1988), with the 
calculation for this being: 
d = (M1 – M2) ⁄ SD pooled 
  where, SD pooled = √((SD12 + SD22) ⁄ 2) 
Cohen’s power primer definitions were used to interpret the effects sizes found in the 
between group differences: ‘small’ (d = 0.2), ‘medium’ (d = 0.5) or ‘large’ (d = 0.8) (Cohen, 
1988). 
 Secondary analyses also investigated any differences in the number of treatment 
sessions received in each of the treatment groups. Furthermore, measures of clinically 
significant change (CSC) and reliable change (RC) was completed to highlight any changes 
within groups of change from pre- to post-treatment. The CSC would indicate whether an 
individual had made meaningful and significant change from a point of being within a 
‘clinical population range’ (i.e., dysfunctional) to being within a ‘non-clinical range’ (i.e., 
functional) (Jacobson, Follette, & Ravenstorf, 1984). The RC would indicate whether an 
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individual’s scores had changed more than would be determined by that of error inherent 
within the measure (Jacobson & Truax, 1991). These comparisons were completed on the 
PHQ-9 and GAD-7 measure only. 
3. Results 
3.1 Sample inclusion 
 Datasets were prepared and PSM methodology applied to generate the final sample 
for the analysis as previously outlined. The route to sample inclusion is shown 
diagrammatically in Figure 2. 
3.2 Sample characteristics 
3.2.1 Baseline measures and demographics 
 Table 1 summarises the demographics, including baseline outcome measures, that 
were eligible for inclusion before PSM procedures (CAT n = 76; CBT n = 424). Independent 
samples Mann Whitney-U and chi-square tests were used to compare all those who had 
completed CBT or CAT treatments on these characteristics. There were no significant age 
differences between those who were treated using CBT and those who were treated using 
CAT (p=0.119; CBT M = 40.45 (15.08), CAT M = 42.58 (11.96), and gender was equally 
distributed between the therapies (p=0.879; CBT 64% = female, CAT 63% = female). 
Comparing the number of treatment sessions attended between the therapies resulted in a 
non-significant finding (p=0.071; CBT M = 9.19 (6.90), CAT M = 9.80 (5.59). Baseline 
outcome measures (compared using Mann Whitney-U tests), indicated significant differences 
between the distribution of scores on each measure (p<0.05) with the CAT cases tending to 
report greater levels of depression (CAT M = 18.12 (5.08); CBT M = 16.42 (5.92)), anxiety 
(CAT M = 14.85 (4.39); CBT M = 13.34 (5.37)) and functional impairment (CAT M = 24.52 
(8.72); CBT M = 21.51 (9.32)).
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All cases All CAT cases All CBT cases 
n 
 
2078 76 424 
Age: mean (SD; range) 
 
 
41.77 (15.07; 18-93) 42.58 (11.96; 18-75) 40.45 (15.08; 18-82) 




Male: 685 (33) 
Female: 1392 (67) 
n=1 missing 
Male: 28 (37) 
Female: 48 (63) 
Male: 152 (36) 




mean (SD; range) 
 
n=465 
16.69 (5.82; 0-27) 
n=73 
18.12 (5.08; 6-27) 
n=392 
16.42 (5.92; 0.27) 
 
GAD-7_session 1: 
mean (SD; range) 
 
n=465 
13.57 (5.25; 0-21) 
 
n=73 
14.85 (4.39; 0-21) 
n=392 
13.34 (5.37; 0.21) 
 







24.52 (8.72; 1-40) 
n=381 
21.51 (9.32; 0-40) 
No. of sessions: mean 
(SD; range) 
 
6.86 (5.17; 2-40) 9.80 (5.59; 2-28) 9.19 (6.90; 2-40) 
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3.2.2 Propensity score matching samples 
 To assess the accuracy of the propensity score matching (PSM) procedure, the 
baseline characteristics of the filtered PSM sample was compared using Mann Whitney-U 
and chi-square tests. Table 2 summarises the demographics, including baseline outcome 
measures, for the PSM sample. 
3.2.3.1 PSM dataset 
 Baseline demographic factors, age and gender, showed no significant differences 
between those who received CAT or CBT treatment in this PSM subsample. The first session 
PHQ-9 and GAD-7 outcome measures were also matched sufficiently. However, significant 
minimal differences were evident following the matching in the baseline WSAS scores 
between groups (t(144) = 2.082, p<0.05; CBT M = 21.63 (8.04), CAT M = 24.52 (8.72)). 
‘Caseness’, i.e., whether an individual scored above the clinical cut-off range on outcome 
measures is also highlighted for the PHQ-9 (clinical range = ≥ 10) and GAD-7 (clinical range 
= ≥ 8) measures (p=0.092). 
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Table 2: Characteristics of the PSM samples 
Note: * Mann Whitney-U conducted except for Gender and PHQ-9/GAD-7 caseness data where Chi square conducted; p-level compares PSM CAT cases with PSM CBT cases.
Characteristics  PSM CAT PSM CBT p-level* 
n  76 73  






























































     
GAD-7_severity 

















  69 (95) 
 
63 (86) p=.0.93 
    p<0.05 
GAD-7_casesness start: 
no (%) 
 70 (99) 62 (85)  
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3.4 Primary analysis 
 The primary analysis was conducted on the PSM sample (n=149; CAT=76, CBT=73) and 
was separated across outcome measures (Table 2). Four unconditional models based on different 
trends (linear, quadratic, cubic, loglinear) were initially built and -2*loglikelihood (-2LL) change 
was compared to find the model with the best fit. Following this, growth curve modelling was 
used, and a conditional model was built including the Sample variable (i.e., which treatment 
modality was received; CAT or CBT) as a predictor. 
 From the PHQ-9 primary analysis, the Sample*Time interaction term (primary 
hypothesis test) was not statistically significant (B = 0.33, SE = 0.22, p=0.138) indicating that 
trajectories of change over time in depression symptoms between treatment modality groups 
(CAT, CBT) did not significantly differ (i.e., the different treatments did not have differential 
effects on symptoms over time). Thus, patients receiving either CAT or CBT had on average 
similar PHQ-9 scores and change profiles over treatment time. The effect of Time was 
significant (B = 0.065, SE = 0.028, p<0.019) indicating that change does occur over sessions. 
Baseline severity was not significantly different between the two samples (B = -1.70, SE = 0.90, 
p=0.061). Symptomatic change on the PHQ-9 followed a quadratic trend (see Figure 3). 
 From the GAD-7 primary analysis, the Sample*Time interaction term was not significant 
(B = 0.11, SE = 0.19, p=0.566) indicating that trajectories of change over time on anxiety 
symptomatology between therapies were not significantly different. Thus, the patients receiving 
either CAT or CBT had similar GAD-7 change scores and outcome trajectories over time. There 
was a significant effect of a linear trend for Time (p<0.0001) but not of Sample (p=0.537), 
indicating that whilst GAD-7 outcome scores did significantly change as a function of Time, 
there was no significant differences in initial severity on the GAD-7 between CAT and CBT. 
10 years of IAPT: a meta-analysis              120 
Symptomatic change on this measure of anxiety followed a linear trend and this can be viewed 
visually (Figure 4). From the visual representation, the two treatments appear to follow a similar 
linear trajectory from session 1 to session 8. 
From the WSAS primary analysis, the Sample*Time interaction term was again not 
significant (B = 0.48, SE = 0.31, p=0.121) indicating that trajectories of change over time on 
levels of functioning between CAT ad CBT were not significantly different (i.e., functioning 
changes occurred similarly over time between the therapies). Thus, the patients receiving either 
CAT or CBT had on average similar WSAS change scores over time. There was a significant 
effect of a linear Time trend (p<0.0001) but not of Sample (p=0.076), indicating that whilst 
WSAS scores did significantly change as a function of Time, there was no significant differences 
in initial severity on this measure of functioning between groups. Symptomatic change on the 
WSAS followed a linear trend and this can be viewed visually in Figure 5. From the visual 
representation, the linear model appears similar to that of the GAD-7 analysis in that the two 
treatments appear to follow a similar trajectory from session 1 to session 8.
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Figure 3: Sample*Time growth curve model showing a quadratic trend in the PHQ-9 data 
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Figure 4: Sample*Time growth curve model showing a linear trend in the GAD-7 data 




Figure 5: Sample*Time growth curve model showing a linear trend in the WSAS data 
 
3.5 Secondary analyses 
3.5.1 Sensitivity analyses: effect size comparisons, treatment sessions, drop-out and change 
 Between-group post-treatment effect sizes were compared for each outcome measure 
using Cohen’s d (Table 3). In the combined dataset of all PSM cases, the outcome measures 
showed between-group effect sizes in the small to minimal range. When the number of treatment 
sessions attended was compared this indicated a significant difference in the average number of 
CAT and CBT treatment sessions (t(144) = 2.890, p<0.004). This showed that CAT had a 
significantly higher number of treatment sessions completed (M = 6.01 (2.54)) compared to the 
CBT treatment group (M = 4.74 (2.78)) in the PSM samples. 
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Table 3: Effect size data from the PSM dataset 





  Group  
  CAT CBT  
 Outcome 
measure 
mean (SD) mean (SD)  













In regards to drop-out rates (indicated by those ceasing therapy before session 3), within the CBT 
group, n=21 (28.8%) patients left therapy =<session 2, whilst within the CAT group n=11 
(15.1%) patients left therapy =<session 2. In addition, clinically significant change and reliable 
change was examined to highlight any changes between pre- and post-intervention in each 
treatment group (Table 4). The results indicate that both treatment groups had a similar number 
of individuals meeting ‘caseness’ (and thus, similar number not meeting ‘caseness’) following 
treatment, with 60% of individuals still meeting ‘caseness’ on the PHQ-9 measure, and 59-62% 
on the GAD-7 measure. 
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Table 4: Clinically significant change and reliable change from the PSM datasets 
  Group 
  CAT CBT 




































Note: ‘Caseness’ refers to the number (and percentage) of individuals who continued to score above clinical cut-offs on the outcome measures at 




The present pilot study aimed to analyse practice-based outcomes data from patients who 
accessed CAT or CBT for common mental health problems in an IAPT service. The focus on 
outcomes for brief 8-session CAT in IAPT contributes to the CAT evidence base which has few 
studies of outcome for anxiety and depression (Calvert & Kellett, 2014). This analysis was 
innovative as it was completed using longitudinal multilevel modelling techniques to investigate 
the trajectory of change over time in treatment groups matched on baseline characteristics 
through propensity score matching methods. Secondary analyses examined between-group effect 
sizes, treatment length and rates of reliable and clinically significant change. 
The main findings from the primary analysis indicate no significant differences between 
treatment modalities were evident on symptom change over time. In other words, patients 
accessing either CAT or CBT experienced similar patterns of change in depression, anxiety, and 
functioning over sessional time. The propensity score matching procedure used to enable this 
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comparison derived comparable samples, which strengthens the credibility of the main findings 
of little differences being apparent in terms of outcome. From the unmatched sample, all baseline 
symptom measures significantly differed between groups. This may have been due to the CAT 
sample being offered to patients with identified interpersonal difficulties and complex life 
histories. This was minimised in the PSM sample as any differences on baseline depression or 
baseline anxiety scores were minimal (not significant), and only differences on baseline WSAS 
scores remained albeit minimally. 
The findings indicate that patients accessing either therapy tended to experience a 
decrease (i.e., improvement) in symptom severity over time. This outcome confirms the 
hypothesis that the treatment outcomes of CBT and CAT would not be significantly different. 
The findings here compliment an extensive literature of work identifying similarities in treatment 
outcomes across therapeutic models. In 1977, Smith and Glass reported similar results to the 
findings in the current study with no significant differences being found when comparing the 
treatment effectiveness of behavioural and non-behavioural therapies. In subsequent research 
outputs, authors have further investigated this using sophisticated meta-analyses techniques and 
have added further support to this finding. For example, comparisons between CBT and other 
psychotherapies (e.g., IPT) have found no significant differences in regard to treatment outcomes 
(Cuijpers et al, 2013; Cuijpers et al, 2017). Furthermore, meta-analyses techniques have been 
utilised to investigate treatment formats in relation to treatment outcomes, and findings have 
indicated that in treatments which have a human element (i.e., where the patient is supported by 
a therapist) each is as effective as the other (Cuijpers et al, 2019). The treatment formats include 
individualised therapy, group work, telephone intervention and guided self-help. In addition, this 
work found that where a human element was not present, i.e., in unguided self-help, treatment 
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outcomes were significantly lower than the other formats (Cuijpers et al, 2019). In terms of 
implications for services, this body of evidence adds support for alternative formats to individual 
therapy being offered, which is consistent with the IAPT model of working. This also fits with a 
recent finding reported in a meta-analysis review of evidence-based research studies (Wakefield 
et al., in press). This study indicated that group-based formats delivered within the IAPT model 
were comparatively as effective as individual formats. With more formats being offered which 
have been shown to be similarly effective, services have the potential to be able to make 
therapeutic interventions more accessible to a wider population. 
Despite the clear theoretical differences between the treatment studies here, there was a 
non-significant difference of outcome, suggesting a common pan-model mechanism of action. 
The equivalence paradox also forwards the idea the common therapeutic actions shared by 
psychotherapies. This is despite the case that both interventions have differing model 
assumptions and approaches, such as with CBT and CAT. CBT is a model of therapy based on 
the inter-related relationship between a person’s own thoughts, feelings, behaviour and 
physiology, and uses a range of both cognitive and behavioural techniques to challenge unhelpful 
behaviour or thinking patterns. In contrast, CAT has a key therapeutic aim of building a 
therapeutic relationship to allow re-enactments of reciprocal roles to be explored in and out of 
the room in the effort to build a greater range and flexibility of roles and procedures. 
The current sample within this research project, both within CAT and CBT treatments, 
either entered treatment within the IAPT service at step 3 (high intensity) or were ‘stepped up’ to 
step 3, which would indicate that their initial symptom severity was severe enough to warrant a 
high intensity intervention. A current growing body of research has highlighted other sources of 
heterogeneity that could have an impact on treatment outcomes. These include patient 
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characteristics (e.g., deprivation level; Delgadillo et al., 2016) and service-level factors (e.g., 
number of sessions, size of service; Gyani et al., 2013). 
Another area of research investigating factors related to outcome change is therapist 
effects, i.e., the degree to which patients treated by different therapists have similar treatment 
outcomes. There has been variation between studies reporting therapist effects, and a recent 
systematic review indicated a therapist effects range of 0.2-29% from different study designs (the 
majority being practice-based) and further supported the notion that it matters most who the 
therapist is to those who enter treatment with higher baseline symptom severity (Johns et al., 
2019). IAPT-specific therapist effects have been researched and evidence has indicated a 6.7% 
effect in combined low and high intensity interventions (Pereira et al., 2016), and a 5.8% effect 
on treatment outcomes in high intensity interventions undertaken within the IAPT programme 
(Saxon et al., 2016). Further work is currently being investigated and that potentially links in 
with the IAPT model well is around outcome feedback (OF). The IAPT model monitors and 
collects outcome sessional data and this is one of the key components of the model. It may be 
that OF is a potential next step in the IAPT evolution as OF technology takes those outcomes and 
encourages therapists to spend time at each session going through changes with the individual 
client. It can also be utilised within supervision to track clients progress and identify clients 
deemed ‘not on track’. Research outcomes into this area have shown that in comparisons 
between those clients treated by therapists using OF and those clients by therapists not using OF, 
treatment outcomes did not show significant differences however the average length of treatment 
was shorter in the OF condition and thus the cost of treatment was less (Delgadillo, Overend, 
Lucock, Groom, Kirby, et al., 2017). Again, this research is mostly focussed in CBT 
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interventions although could be extended to further interventions and psychological models 
within the IAPT services. 
Time did indicate a significant effect, i.e., change on outcome measures occurs over 
sessions, and did so in a decreasing manner (i.e., improvement). Whilst this is not a surprising 
finding, it did indicate that both sample groups, on average, showed decreases in symptom 
severity pre-post treatment with a trajectory that generally showed a steeper reduction in 
outcome scores in the earlier sessions of the intervention. One line of research has proposed that, 
specifically in CBT interventions, those with depression or anxiety symptomatology and who 
show early gains are more likely to have better outcomes post-treatments than those who do not 
report early gains (Aderka, Nickerson, Boe & Hofmann, 2012) and this finding may be extended 
to CAT interventions at least in the briefer form reported here in the current study. 
As a psychological treatment, CAT was presented as a time-limited therapy offering 16-
24 sessions for individuals experiencing a range of mental health difficulties (Ryle & Kerr, 
2002). Whilst this treatment length can be considered a short-term therapy next to the more 
traditional psychotherapies offered that were delivered, the findings from the present study 
indicate that CAT can have positive effects delivered in a much shorter timeframe. CAT has 
expanded over the past decade and research studies into the use of CAT with other populations 
are gaining momentum including beneficial effects being found with those struggling with eating 
disorders (Treasure et al., 1995), morbid jealousy (Kellett & Totterdell, 1995), and following 
acquired brain injuries (Yeates et al., 2008). Furthermore, CAT has also been shown to be 
successful when delivered as a group intervention (Calvert et al., 2015) and more recently has 
been used within a randomised dismantling trial for depression (Kellett et al., 2018). Positive 
outcomes following therapy with those struggling with depression and anxiety have also been 
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reported (Hamill & Mahoney, 2011). A recent meta-analysis indicated significant reductions in 
depression symptomatology following CAT intervention (Hallam, Simmonds-Buckley & Kellett, 
2020). Whilst CBT is the NICE recommended treatment of choice for both these latter problems 
(CG90; CG113), CAT can be recommended via clinical judgement when CBT is not warranted 
(either by the therapist or client themselves), however it has not been until more recently that 
CAT has been offered as a therapeutic option within the IAPT programme. A low dropout rate 
for CAT has been previously identified (Calvert & Kellett, 2014). In the current study, 15% of 
CAT patients left therapy prior to session 3 which fits with the current literature around drop-out 
rates within CAT. A recent meta-analysis reported that drop-out rates ranged between 0-38% 
(average = 23%) from those accessing CAT (Hallam et al, 2020). The evidence presented here in 
the present study further contributes to the benefits of CAT and without it being inferior to CBT. 
Whilst the IAPT programme does have a reputation for relying heavily on cognitive-
behavioural treatments, more recently researchers have begun to question the differential effect 
of CBT as a NICE-recommended treatment for depression, as outcomes between CBT and 
counselling treatments have found the two to be generally comparable (e.g., Pybis et al., 2017). 
Both are step-3 or ‘high-intensity’ treatment and studies have shown the benefits of CBT 
following more intensive (longer) treatments (above 8 sessions) whilst counselling for 
depression has been reported as showing more improvement in recovery rates in briefer forms 
(2-7 sessions). In the current study, when investigating CAT and CBT with similar average 
treatment lengths, they showed similar change trajectories over time. 
4.1 Critique of the present study 
The current study is limited by the lack of randomisation to treatment groups and also 
lack of any follow-up data. This is particularly a limitation, as the CAT model stresses the 
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importance of endings and structured follow-up. The current study was also unable to investigate 
adherence to the model or competence of the therapists. There is an extant measure of CAT 
competency (e.g., Bennett & Parry, 2004) and the Revised Cognitive Therapy Scale (CTS-R; 
James, Blackburn & Reichelt, 2001) is a well-established CBT competency tool. Some argue that 
adhering to the recommended protocol is key to treatment outcomes (e.g., Waller, 2009) and that 
trained practitioners are aware of the evidence-based therapeutic protocols, yet evidence has 
shown that they are used sparingly in practice (e.g., Waller, Stringer & Mayer, 2012). Thus, 
having ways to monitor fidelity to the treatment offered can ensure that what is reported as being 
the therapeutic intervention is in fact being delivered. Within IAPT services, including the ones 
within this current study, manualised protocols are employed to those attending treatment 
sessions. The IAPT programme has also recognised that supervision, both clinical and case-
management, are integral to delivering the stepped-care model and thus guidelines have been 
produced to support this process, which can be used as one way to ensure fidelity to treatment 
protocols and reduce therapeutic drift (IAPT Supervision Guidance, 2011). On the contrary, it is 
also important to recognise that others have reported that more experienced therapists may be 
able to understand when it is appropriate to ‘drift’ (known as ‘therapist drift’) from the protocol 
and still maintain positive treatment outcomes (Tschuschke et al., 2015). Without being able to 
monitor the fidelity or competency within the current study, we are unable to comment here on 
whether these factors had any influence on the findings, yet this is an area of research that could 
be progressed in future studies. 
The analysis used here, namely, longitudinal MLM, allows for the modelling of 
trajectories over time, which is particularly systematic and robust when dealing with large 
amounts of data from a programme such as IAPT. The data presented here consisted of a 
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hierarchical structure whereby scores on outcome measures were nested within patients, and the 
MLM procedure is able to handle issues surrounding missing data and correlated variables (i.e., 
the assumption of independence). Being able to input random effects into MLM makes the 
model more accurate when analysing data from clinical practice, rather than assuming effects 
(e.g., baseline scores) are fixed across groups. Non-parametric tests were utilised to compare 
baseline characteristics between groups, which takes into account skewness in the data. The PSM 
method is a valid statistical tool that mimics the randomisation procedure used in RCTs to match 
groups as equivalent as possible on important factors and is recommended for such a task (Beal 
& Kupzyk, 2014). The matching within the present study was done to an acceptable level, with 
minimal differences between groups following the procedure, augmenting the strength of the 
findings. 
Despite this, there are still areas of potential limitation within the present study that 
should be addressed. One of the limitations of this study design was that the propensity score 
matching procedure yielded balanced samples on most baseline characteristics, but some 
imbalance remained in some features (WSAS) and in sample sizes (CAT n=76; CBT n=73). 
Although the PSM procedure is a methodologically robust approach in contexts where 
randomisation is not feasible or ethical (Rosenbaum & Rubin, 1983), it is nevertheless possible 
that the imperfect balancing of covariates may have introduced some bias into the analysis. 
Whilst the number of treatment sessions received was compared, other areas of interest that the 
study was unable to investigate include the dropout rate between the two treatments which may 
have further enhanced the understandings of the two offered therapies. Another drawback of the 
current study is the lack of any follow-up. Therefore, whilst this study provides preliminary 
information about the comparison between two high intensity interventions delivered within the 
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UK IAPT programme, future research should look to investigate whether the findings are 
maintained over time. 
The advantages and disadvantages of using pre-existing data sets have been discussed 
within the literature. Regarding the data set in question here, there are specific advantages to 
conducting this research study. Firstly, the data has been collected as part of routine clinical 
practice in two working IAPT services. In the dataset, CAT as a treatment was being piloted and 
therefore, since there became a sufficient amount of completed data to analyse, it is ethically 
compelling to investigate whether this specific type of therapy is of benefit to this population. 
Furthermore, time and effort on behalf of the patients receiving this treatment in completing 
sessional outcome measures has been spent, and whilst they may be utilised in individual 
sessions, an ethical case may be made for utilising the data set as a whole to investigate whether 
this type of therapy is appropriate, and the results may be used for service development (e.g., by 
way of rolling it to other IAPT services if benefits are found). Secondly, the use of a separate 
researcher/team to carry out an analysis of the data, as opposed to it being carried out by those 
involved in data collection and potentially being the ones giving the treatment, reduces bias and 
means that conflicts of interest are not present and thus bias in the interpretation of the results is 
minimised.  Clearly, capturing follow-up data of CAT outcomes in IAPT services is at a 
premium.   
4.2 Clinical, service and research implications 
 In terms of clinical and service implications, the results of this pilot practice-based study 
add some support for the effectiveness of analytically informed therapies for those accessing 
IAPT services. The study has been novel as it has been the first to study brief high intensity CAT 
in IAPT and so supplements the evidence concerning low intensity CAT in IAPT (Meadows & 
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Kellett, 2015). Patients with anxiety and depression deserve access to a range of psychological 
therapies and services need to make more use of offering informed choice. Whilst the preference 
for psychological therapy over pharmacological treatment is well established (McHugh, Whitton, 
Peckham, Welge, & Otto, 2013), less is known about patient preferences for psychological 
therapies and also the role of matching patients to therapies. The results presented here indicate 
no significant difference between the two treatments which suggests that CAT has a potential 
role to play in IAPT not only for those individuals who decline or do not benefit from CBT, but 
also as a first-line treatment. The development of the brief 8-session model of CAT seems to be 
well suited to IAPT particularly in which the average session attendance is 7 sessions.   
In terms of research implications, a further way to investigate whether CAT is acceptable 
in this population accessing psychological treatments is to conduct patient-preference trials 
whereby CAT is offered to patients alongside other therapies with one outcome indicating the 
potential uptake of treatments alongside those already offered. The future evaluation of the brief 
8-session CAT model would benefit from the addition of follow-ups to the methodology to 
assess the durability of the intervention. It would also be interesting to compare the outcomes for 
PIT and DIT with CAT in IAPT, although again, these are delivered in longer formats. The use 
of disorder-specific IAPT outcome measurement would also be a valuable way of evaluating 
effectiveness of the 8-sesion model. Finally, including treatment integrity checks would be a 
valuable addition to the methods of any future CAT in IAPT outcome research. 
As the current study investigated average differences, what it was unable to answer was 
whether some patients may respond better and thus benefit more from one type of therapy over 
the other. This should be investigated in other work by observing the individual personalised 
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differences to treatments and whether patient characteristics could influence preferential 
treatment offered. 
4.3 Conclusions 
 The UK Government set the agenda to achieve a ‘parity of esteem’ between mental and 
physical health services (Department of Health, 2012) and one important step in this has been the 
IAPT programme. Following the national roll-out of the programme in 2008, IAPT has been 
developing and evolving in many ways, with one of these being in widening the range of high 
intensity therapies that the programme offers. This study has compared outcomes on well 
matched cases of CAT and CBT to find that few differences between the therapies emerged in 
the longitudinal MLM analyses. Therefore, the study adds to the voluminous evidence base of 
the equivalence of outcomes between psychotherapies when they are delivered in routine 
practice settings. The 8-session CAT model appears to have good acceptability with patients and 
is matched in terms of its effectiveness with CBT; the advantage of the model is its brevity and 
the fact that it is delivered in 8-sessions whilst retaining fidelity to the reformulation, recognition 
and revision structure of the model. Further, more controlled investigations of the effectiveness 
and efficacy of the brief 8-sesion model in IAPT appear therefore indicated. 
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Appendices 
1. PHQ-9 outcome measure scale 
*Copyright material removed. 
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2. GAD-7 outcome measure scale 
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3. WSAS outcome measure scale 
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